14534335	25	Hughes TP	Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.	The New England journal of medicine	2003	171
15251979	25	Pui CH	Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.	Blood	2004	105
15867244	25	Cortes J	Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.	Clinical cancer research 	2005	76
16344315	25	Yanada M	High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.	Journal of clinical oncology 	2006	61
16775234	25	Talpaz M	Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.	The New England journal of medicine	2006	351
17189410	25	Soverini S	Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.	Clinical cancer research 	2006	98
17496201	25	Ottmann O	Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study.	Blood	2007	73
17785585	25	Cortes J	Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors.	Blood	2007	58
18477770	25	Porkka K	Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.	Blood	2008	58
18541900	25	Shah NP	Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.	Journal of clinical oncology 	2008	104
19369233	25	Quintás-Cardama A	Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia in early chronic phase receiving high-dose or standard-dose imatinib therapy.	Blood	2009	50
19779040	25	Müller MC	Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations.	Blood	2009	66
19822896	25	Rosti G	Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia.	Blood	2009	51
20525993	25	Saglio G	Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.	The New England journal of medicine	2010	259
20679528	25	Hughes TP	Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS).	Blood	2010	102
22446502	25	Hanfstein B	Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).	Leukemia	2012	74
22493293	25	Gökbuget N	Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation.	Blood	2012	43
23620574	25	Jain P	Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities.	Blood	2013	26
23794064	25	Soverini S	Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain.	Blood	2013	37
24180494	25	Cortes JE	A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.	The New England journal of medicine	2013	123
24297946	25	Hehlmann R	Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV.	Journal of clinical oncology 	2014	43
24311723	25	Jabbour E	Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION).	Blood	2014	56
7570001	100	Blaese RM	T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.	Science	1995	145
12089448	100	Aiuti A	Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.	Science	2002	219
15032591	100	Buckley RH	Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution.	Annual review of immunology	2004	102
19179314	100	Aiuti A	Gene therapy for immunodeficiency due to adenosine deaminase deficiency.	The New England journal of medicine	2009	229
19638621	100	Gaspar HB	How I treat ADA deficiency.	Blood	2009	46
21865538	100	Gaspar HB	Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction.	Science translational medicine	2011	64
22968453	100	Candotti F	Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.	Blood	2012	53
27129325	100	Cicalese MP	Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.	Blood	2016	13
9731568	174	-	A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.	Hepatology	1998	231
11156649	174	Bolondi L	Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.	Gut	2001	103
12029639	174	Hsu YS	Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.	Hepatology	2002	100
15665226	174	Lencioni R	Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.	Radiology	2005	112
16246200	174	Natsuizaka M	Clinical features of hepatocellular carcinoma with extrahepatic metastases.	Journal of gastroenterology and hepatology	2005	90
16542289	174	Farinati F	Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?	The American journal of gastroenterology	2006	68
16778155	174	Terai S	Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.	Stem cells	2006	94
18069697	174	Forner A	Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.	Hepatology	2008	124
18972441	174	Zhang L	The stem cell niche of human livers: symmetry between development and regeneration.	Hepatology	2008	65
19064965	174	Chan SL	New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.	Journal of clinical oncology 	2009	56
19302335	174	Nguyen VT	Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.	Journal of viral hepatitis	2009	67
19731239	174	N'Kontchou G	Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.	Hepatology	2009	55
19766639	174	Salem R	Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.	Gastroenterology	2010	158
20821352	174	Ghodsizadeh A	Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells.	Stem cell reviews	2010	42
21618574	174	Sangro B	Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.	Hepatology	2011	109
22374994	174	Singal AG	Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.	Cancer epidemiology, biomarkers and prevention 	2012	49
22846859	174	Bertino G	Hepatocellualar carcinoma serum markers.	Seminars in oncology	2012	37
24096763	174	Zhong JH	Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.	Annals of surgery	2014	69
24836552	174	Takeda H	Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan.	Liver international 	2015	17
24912628	174	Memeo R	Laparoscopic vs. open liver resection for hepatocellular carcinoma of cirrhotic liver: a case-control study.	World journal of surgery	2014	26
25804634	174	Xu X	Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.	Gut	2016	17
26628466	174	Wahl DR	Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.	Journal of clinical oncology 	2016	20
27422750	174	Hocquelet A	Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC.	Journal of hepatology	2017	5
14742691	268	Weenen C	Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.	Molecular human reproduction	2004	156
16923748	268	La Marca A	Serum anti-Mullerian hormone throughout the human menstrual cycle.	Human reproduction	2006	74
19136673	268	Nelson SM	Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception.	Human reproduction	2009	48
19520713	268	La Marca A	Anti-Mullerian hormone (AMH): what do we still need to know?	Human reproduction	2009	55
19793843	268	La Marca A	Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).	Human reproduction update	2010	120
21789206	268	Kelsey TW	A validated model of serum anti-müllerian hormone from conception to menopause.	PloS one	2011	54
22137491	268	Gracia CR	Impact of cancer therapies on ovarian reserve.	Fertility and sterility	2012	31
24345633	268	Dewailly D	Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.	Human reproduction update	2014	21
16831965	361	Pittock SJ	Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.	Archives of neurology	2006	103
17282996	361	Roemer SF	Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.	Brain 	2007	143
18434643	361	Matiello M	NMO-IgG predicts the outcome of recurrent optic neuritis.	Neurology	2008	58
18945724	361	Jarius S	Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.	Brain 	2008	84
20825655	361	Jarius S	Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.	Journal of neuroinflammation	2010	44
21368286	361	Popescu BF	Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications.	Neurology	2011	57
21536639	361	Asgari N	A population-based study of neuromyelitis optica in Caucasians.	Neurology	2011	38
21550068	361	Jarius S	Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.	Journal of the neurological sciences	2011	41
22128336	361	Hinson SR	Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.	Proceedings of the National Academy of Sciences of the United States of America	2012	65
22260418	361	Jarius S	Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.	Journal of neuroinflammation	2012	91
22371853	361	Rostasy K	Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis.	Archives of neurology	2012	30
22733096	361	Mealy MA	Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.	Archives of neurology	2012	35
22914827	361	Kitley J	Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.	Neurology	2012	68
23257621	361	Rostásy K	Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.	Multiple sclerosis	2013	33
23623397	361	Pittock SJ	Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.	The Lancet. Neurology	2013	53
23658379	361	Marignier R	Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.	Neurology	2013	26
24415568	361	Sato DK	Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.	Neurology	2014	73
24700511	361	Titulaer MJ	Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.	Annals of neurology	2014	43
25344373	361	Höftberger R	Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.	Multiple sclerosis	2015	27
25695963	361	Kim HJ	MRI characteristics of neuromyelitis optica spectrum disorder: an international update.	Neurology	2015	32
26092914	361	Wingerchuk DM	International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.	Neurology	2015	143
11395009	627	Aakalu G	Dynamic visualization of local protein synthesis in hippocampal neurons.	Neuron	2001	165
12851636	627	Weickert CS	Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia.	Molecular psychiatry	2003	106
15537879	627	Pezawas L	The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology.	The Journal of neuroscience 	2004	240
16458264	627	Kaufman J	Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children.	Biological psychiatry	2006	164
17482146	627	Kim JM	Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders.	Biological psychiatry	2007	73
18632683	627	Mellios N	A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex.	Human molecular genetics	2008	81
18752720	627	Brunoni AR	A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.	The international journal of neuropsychopharmacology	2008	118
18753648	627	Han JC	Brain-derived neurotrophic factor and obesity in the WAGR syndrome.	The New England journal of medicine	2008	72
18817811	627	Cirulli F	Early life stress as a risk factor for mental health: role of neurotrophins from rodents to non-human primates.	Neuroscience and biobehavioral reviews	2009	50
19150054	627	Roth TL	Lasting epigenetic influence of early-life adversity on the BDNF gene.	Biological psychiatry	2009	293
19745020	627	McHughen SA	BDNF val66met polymorphism influences motor system function in the human brain.	Cerebral cortex	2010	48
20194826	627	Keller S	Increased BDNF promoter methylation in the Wernicke area of suicide subjects.	Archives of general psychiatry	2010	63
20702043	627	Bus BA	Determinants of serum brain-derived neurotrophic factor.	Psychoneuroendocrinology	2011	41
23422958	627	Perroud N	Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene.	Translational psychiatry	2013	40
24912158	627	Gideons ES	Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.	Proceedings of the National Academy of Sciences of the United States of America	2014	38
27113997	627	Qin XY	Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).	Molecular psychiatry	2017	6
17557426	717	Redline S	The scoring of respiratory events in sleep: reliability and validity.	Journal of clinical sleep medicine 	2007	72
24223212	717	O'Hanlon DE	Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota.	PloS one	2013	41
26207160	717	D'Amato G	Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization.	The World Allergy Organization journal	2015	22
1322294	920	Lewis P	Human immunodeficiency virus infection of cells arrested in the cell cycle.	The EMBO journal	1992	180
1361652	920	-	1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.	MMWR. Recommendations and reports 	1992	637
7540117	920	Fisher GH	Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.	Cell	1995	207
7675046	920	Walter EA	Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.	The New England journal of medicine	1995	327
7935654	920	Connor EM	Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.	The New England journal of medicine	1994	399
9063413	920	Comans-Bitter WM	Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations.	The Journal of pediatrics	1997	111
10232312	920	Wiktor SZ	Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.	Lancet	1999	106
11009139	920	Whitworth J	Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study.	Lancet	2000	106
11117912	920	Greub G	Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.	Lancet	2000	151
11255423	920	Ickovics JR	Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.	JAMA	2001	232
11348697	920	Siegrist CA	Neonatal and early life vaccinology.	Vaccine	2001	132
11585784	920	Lawn SD	Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.	Clinical microbiology reviews	2001	88
11794218	920	Gortmaker SL	Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.	The New England journal of medicine	2001	99
11873003	920	Morgan D	HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?	AIDS	2002	89
11953469	920	French N	Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.	AIDS	2002	100
12037148	920	Herold KC	Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.	The New England journal of medicine	2002	270
12126821	920	Egger M	Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.	Lancet	2002	381
14610491	920	Shearer WT	Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.	The Journal of allergy and clinical immunology	2003	152
14715541	920	Lugada ES	Population-based hematologic and immunologic reference values for a healthy Ugandan population.	Clinical and diagnostic laboratory immunology	2004	95
15034567	920	Reece WH	A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.	Nature medicine	2004	86
15247338	920	Lallemant M	Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.	The New England journal of medicine	2004	104
15247339	920	Jourdain G	Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.	The New England journal of medicine	2004	105
15464184	920	Newell ML	Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.	Lancet	2004	324
15488218	920	Mermin J	Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.	Lancet	2004	109
15555666	920	Chintu C	Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.	Lancet	2004	96
15608532	920	Gebo KA	Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.	Journal of acquired immune deficiency syndromes	2005	118
15652606	920	Kublin JG	Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study.	Lancet	2005	86
15832830	920	Mannheimer SB	Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence.	AIDS care	2005	79
16182404	920	Bräu N	Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.	Journal of hepatology	2006	89
16284464	920	Lawn SD	Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.	AIDS	2005	172
16319381	920	Severe P	Antiretroviral therapy in a thousand patients with AIDS in Haiti.	The New England journal of medicine	2005	99
16421366	920	Gallant JE	Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.	The New England journal of medicine	2006	193
16549832	920	Engels EA	Elevated incidence of lung cancer among HIV-infected individuals.	Journal of clinical oncology 	2006	77
16645169	920	Titanji K	Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.	Blood	2006	116
16652060	920	Brahmbhatt H	Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda.	Journal of acquired immune deficiency syndromes	2006	71
16670804	920	Bekker LG	Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa.	South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde	2006	66
16691070	920	Etard JF	Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.	AIDS	2006	124
16917006	920	Biggar RJ	Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.	Blood	2006	81
17367540	920	Reddi A	Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.	BMC pediatrics	2007	67
17420427	920	Silverberg MJ	Older age and the response to and tolerability of antiretroviral therapy.	Archives of internal medicine	2007	56
17502729	920	May M	Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.	AIDS	2007	97
17565153	920	Biggar RJ	AIDS-related cancer and severity of immunosuppression in persons with AIDS.	Journal of the National Cancer Institute	2007	93
17585291	920	Marin M	Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).	MMWR. Recommendations and reports 	2007	140
17620755	920	Palombi L	Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.	AIDS	2007	58
17693883	920	Kamya MR	Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.	Journal of acquired immune deficiency syndromes	2007	87
17954540	920	Bolton-Moore C	Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.	JAMA	2007	156
17971562	920	Kidder DP	Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS.	American journal of public health	2007	60
18199042	920	Patel K	Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.	Clinical infectious diseases 	2008	67
18413766	920	Singh H	Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.	Cancer research	2008	99
18435450	920	Engels EA	Cancer risk in people infected with human immunodeficiency virus in the United States.	International journal of cancer	2008	221
18480202	920	Riddler SA	Class-sparing regimens for initial treatment of HIV-1 infection.	The New England journal of medicine	2008	191
18614870	920	Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group.	Response to combination antiretroviral therapy: variation by age.	AIDS	2008	66
18670668	920	Brinkhof MW	Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.	Bulletin of the World Health Organization	2008	177
18797643	920	Boulle A	Antiretroviral therapy and early mortality in South Africa.	Bulletin of the World Health Organization	2008	57
18981768	920	Nash D	Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.	AIDS	2008	80
19020325	920	Violari A	Early antiretroviral therapy and mortality among HIV-infected infants.	The New England journal of medicine	2008	388
19031037	920	Monahan PO	Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya.	Journal of general internal medicine	2009	76
19056990	920	Mold JE	Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.	Science	2008	207
19174797	920	Cremon C	Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.	The American journal of gastroenterology	2009	69
19223334	920	Chi BH	Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia.	International journal of epidemiology	2009	48
19282780	920	Nachega JB	Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.	Journal of acquired immune deficiency syndromes	2009	102
19440326	920	Zolopa A	Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.	PloS one	2009	123
19552661	920	van Oosterhout JJ	Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.	Tropical medicine and international health 	2009	48
19569972	920	Kantor R	Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.	Clinical infectious diseases 	2009	57
19571723	920	Marin B	Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.	AIDS	2009	71
19616720	920	Wawer MJ	Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial.	Lancet	2009	96
19745753	920	Geng EH	Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach.	Journal of acquired immune deficiency syndromes	2010	120
19770514	920	Sauce D	Evidence of premature immune aging in patients thymectomized during early childhood.	The Journal of clinical investigation	2009	65
19818686	920	Guiguet M	Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.	The Lancet. Oncology	2009	140
20004464	920	DART Trial Team.	Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.	Lancet	2010	126
20035164	920	Brady MT	Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.	Journal of acquired immune deficiency syndromes	2010	93
20089951	920	Celum C	Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.	The New England journal of medicine	2010	216
20181972	920	Cain KP	An algorithm for tuberculosis screening and diagnosis in people with HIV.	The New England journal of medicine	2010	87
20234368	920	Daayana S	Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.	British journal of cancer	2010	57
20306555	920	Marinda ET	Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy.	Journal of acquired immune deficiency syndromes	2010	43
20345885	920	Hosseinipour MC	Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.	HIV medicine	2010	45
20380565	920	Antiretroviral Therapy Cohort Collaboration.	Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.	Clinical infectious diseases 	2010	132
20428171	920	Baranzini SE	Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.	Nature	2010	122
20554983	920	Shapiro RL	Antiretroviral regimens in pregnancy and breast-feeding in Botswana.	The New England journal of medicine	2010	159
20559035	920	Wallet MA	Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.	AIDS	2010	55
20586958	920	Ekouevi DK	Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa.	Tropical medicine and international health 	2010	43
20588185	920	Fenner L	Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.	Journal of acquired immune deficiency syndromes	2010	45
20622679	920	Mtapuri-Zinyowera S	Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe.	Journal of acquired immune deficiency syndromes	2010	61
20638120	920	May M	Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.	Lancet	2010	103
20827162	920	Yukl SA	Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.	AIDS	2010	104
20865049	920	Lugada E	Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya.	PloS one	2010	40
20942667	920	Palumbo P	Antiretroviral treatment for children with peripartum nevirapine exposure.	The New England journal of medicine	2010	88
21107266	920	Davies MA	Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration.	Journal of acquired immune deficiency syndromes	2011	39
21173412	920	Long EF	The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.	Annals of internal medicine	2010	49
21173675	920	Koyanagi A	Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.	The Pediatric infectious disease journal	2011	45
21217181	920	Crump JA	Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania.	Clinical infectious diseases 	2011	48
21378535	920	Jani IV	Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing.	AIDS	2011	52
21656145	920	Schwartz SR	High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.	AIDS and behavior	2012	46
21750418	920	Nash D	Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.	AIDS	2011	41
21779407	920	Bloomfield GS	Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya.	PloS one	2011	37
21831714	920	Laurent C	Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.	The Lancet. Infectious diseases	2011	38
21846636	920	Hoft DF	Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.	The Journal of infectious diseases	2011	57
21951656	920	Jani IV	Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study.	Lancet	2011	128
22067665	920	Wandeler G	Outcomes of antiretroviral treatment programs in rural Southern Africa.	Journal of acquired immune deficiency syndromes	2012	35
22156912	920	Rich ML	Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda.	Journal of acquired immune deficiency syndromes	2012	55
22253579	920	Ciaranello AL	What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.	PLoS medicine	2012	31
22267016	920	Hall HI	Retention in care of adults and adolescents living with HIV in 13 U.S. areas.	Journal of acquired immune deficiency syndromes	2012	60
22273267	920	Nglazi MD	Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa.	BMC infectious diseases	2012	34
22286307	920	Wilkinson TM	Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.	Nature medicine	2012	235
22394050	920	Ferguson L	Linking women who test HIV-positive in pregnancy-related services to long-term HIV care and treatment services: a systematic review.	Tropical medicine and international health 	2012	43
22531758	920	Fleishman JA	Establishment, retention, and loss to follow-up in outpatient HIV care.	Journal of acquired immune deficiency syndromes	2012	64
22536323	920	Manabe YC	Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy.	PloS one	2012	30
22615543	920	Gibb DM	Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.	PLoS medicine	2012	37
22716976	920	Violari A	Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.	The New England journal of medicine	2012	71
22784037	920	Baeten JM	Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.	The New England journal of medicine	2012	747
22789644	920	Kim MH	The Tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi.	Journal of the International AIDS Society	2012	44
22916256	920	Chamie G	Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda.	PloS one	2012	35
22944874	920	Althoff KN	U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.	Annals of internal medicine	2012	46
22973181	920	Cornell M	Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.	PLoS medicine	2012	61
23011400	920	Clouse K	Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa.	Journal of acquired immune deficiency syndromes	2013	30
23065532	920	Kalichman SC	Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs.	Journal of general internal medicine	2013	34
23066160	920	Chen JY	Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.	The Journal of infectious diseases	2012	71
23075916	920	Dalal W	Home-based HIV testing and counseling in rural and urban Kenyan communities.	Journal of acquired immune deficiency syndromes	2013	45
23111762	920	Buchacz K	Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.	Antiviral therapy	2013	32
23148285	920	Nayak JL	CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.	The Journal of infectious diseases	2013	27
23172341	920	Stover J	Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children.	Sexually transmitted infections	2012	45
23187940	920	Leroy V	Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.	Journal of acquired immune deficiency syndromes	2013	32
23206835	920	Jia Z	Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study.	Lancet	2013	46
23263176	920	Puthanakit T	Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study.	The Pediatric infectious disease journal	2013	38
23293399	920	Bositis CM	Updates to the World Health Organization's Recommendations for the Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants.	Medical journal of Zambia	2010	40
23315317	920	Hanna DB	Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.	Clinical infectious diseases 	2013	36
23324657	920	Zanni MV	Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men.	AIDS	2013	27
23373540	920	Evans D	Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa.	AIDS research and human retroviruses	2013	41
23395677	920	Su LF	Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults.	Immunity	2013	113
23397353	920	Barron P	Eliminating mother-to-child HIV transmission in South Africa.	Bulletin of the World Health Organization	2013	33
23446514	920	Centers for Disease Control and Prevention (CDC).	Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012.	MMWR. Morbidity and mortality weekly report	2013	81
23473847	920	ARROW Trial team.	Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.	Lancet	2013	47
23647555	920	Ngarina M	Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania.	BMC public health	2013	25
23658850	920	Cota GF	Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison.	PLoS neglected tropical diseases	2013	33
23669157	920	Udeagu CC	Lost or just not following up: public health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care.	AIDS	2013	26
23698354	920	Moyer VA	Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement.	Annals of internal medicine	2013	80
23741772	920	-			2010	325
23780395	920	Hall HI	Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.	JAMA internal medicine	2013	112
23880306	920	Iwuji CC	Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.	Trials	2013	45
23939234	920	Weiser SD	Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda.	AIDS	2014	31
24129370	920	Yehia BR	Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts.	Journal of acquired immune deficiency syndromes	2014	21
24184682	920	Lindemans CA	Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome.	Blood	2014	23
24198226	920	Lahuerta M	Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.	Clinical infectious diseases 	2014	38
24209829	920	Cotton MF	Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.	Lancet	2013	50
24382064	920	Bwakura-Dangarembizi M	A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.	The New England journal of medicine	2014	28
24384692	920	Ananworanich J	Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.	AIDS	2014	23
24419071	920	IeDEA and ART Cohort Collaborations.	Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.	Journal of acquired immune deficiency syndromes	2014	43
24447595	920	Wynberg E	Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review.	Journal of the International AIDS Society	2014	40
24465532	920	Ngarina M	Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania.	PloS one	2014	25
24723284	920	Kojic EM	Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.	Clinical infectious diseases 	2014	24
24771333	920	Ingle SM	Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.	Clinical infectious diseases 	2014	25
24941443	920	Blair JM	Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.	MMWR supplements	2014	24
25036865	920	Rosado MM	Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.	Stem cells and development	2015	15
25254512	920	Mavigner M	Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.	PLoS pathogens	2014	24
25301494	920	Phillips T	Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.	Journal of the International AIDS Society	2014	28
25447326	920	Smith JA	Update on ankylosing spondylitis: current concepts in pathogenesis.	Current allergy and asthma reports	2015	16
25467647	920	Ford N	The future role of CD4 cell count for monitoring antiretroviral therapy.	The Lancet. Infectious diseases	2015	19
25501345	920	Koller M	Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.	Journal of acquired immune deficiency syndromes	2015	17
25512624	920	Crowell TA	Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection.	The Journal of infectious diseases	2015	17
25516189	920	Siedner MJ	Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.	Clinical infectious diseases 	2015	52
25723975	920	Charurat ME	Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria.	Journal of acquired immune deficiency syndromes	2015	16
25726088	920	Ndiaye BP	Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.	The Lancet. Respiratory medicine	2015	24
25775592	920	McElroy AK	Human Ebola virus infection results in substantial immune activation.	Proceedings of the National Academy of Sciences of the United States of America	2015	39
25908663	920	Hepworth MR	Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells.	Science	2015	46
26193635	920	Rigby MR	Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.	The Journal of clinical investigation	2015	20
26348035	920	Choko AT	Uptake, Accuracy, Safety, and Linkage into Care over Two Years of Promoting Annual Self-Testing for HIV in Blantyre, Malawi: A Community-Based Prospective Study.	PLoS medicine	2015	24
26633768	920	Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa.	Sustainable HIV treatment in Africa through viral-load-informed differentiated care.	Nature	2015	34
26657141	920	Thome JJ	Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues.	Nature medicine	2016	24
27019159	920	Bakulski KM	DNA methylation of cord blood cell types: Applications for mixed cell birth studies.	Epigenetics	2016	23
27036993	920	Haas AD	Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.	The lancet. HIV	2016	15
27222480	920	Krejcik J	Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma.	Blood	2016	17
27470028	920	GBD 2015 HIV Collaborators.	Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.	The lancet. HIV	2016	36
28199305	920	Mordmüller B	Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.	Nature	2017	10
7574193	966	Peterson JC	Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.	Annals of internal medicine	1995	129
9565947	966	Trost SG	Validity of the computer science and applications (CSA) activity monitor in children.	Medicine and science in sports and exercise	1998	153
12900431	966	Feig DI	Hyperuricemia in childhood primary hypertension.	Hypertension	2003	82
14707773	966	Riddoch CJ	Physical activity levels and patterns of 9- and 15-yr-old European children.	Medicine and science in sports and exercise	2004	152
17267695	966	Sadowski EA	Nephrogenic systemic fibrosis: risk factors and incidence estimation.	Radiology	2007	105
19218538	966	Schiffmann R	Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy.	Nephrology, dialysis, transplantation 	2009	57
19339091	966	White SL	Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies.	American journal of kidney diseases 	2009	59
19909994	966	Andropoulos DB	Brain immaturity is associated with brain injury before and after neonatal cardiac surgery with high-flow bypass and cerebral oxygenation monitoring.	The Journal of thoracic and cardiovascular surgery	2010	51
20153487	966	Whyte LJ	Effect of 2 weeks of sprint interval training on health-related outcomes in sedentary overweight/obese men.	Metabolism	2010	50
22206744	966	Mammen C	Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study.	American journal of kidney diseases 	2012	52
22340137	966	Ridgers ND	Agreement between activPAL and ActiGraph for assessing children's sedentary time.	The international journal of behavioral nutrition and physical activity	2012	46
22936784	966	Alexander RT	Kidney stones and kidney function loss: a cohort study.	BMJ	2012	37
23022429	966	Wong CJ	CKiD (CKD in children) prospective cohort study: a review of current findings.	American journal of kidney diseases 	2012	30
23111824	966	Hallan SI	Age and association of kidney measures with mortality and end-stage renal disease.	JAMA	2012	95
23714169	966	Singh AK	Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study.	BMC nephrology	2013	30
23782649	966	Worthley SG	Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.	European heart journal	2013	35
25393378	966	Naik RP	Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans.	JAMA	2014	23
25531343	966	Mugwanya KK	Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.	JAMA internal medicine	2015	18
25795794	966	Germain DP	Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease.	Journal of medical genetics	2015	20
10416987	1029	Ishii N	Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.	Brain pathology	1999	155
16251483	1029	Chanda S	DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy.	Toxicological sciences 	2006	67
16964246	1029	Denoyelle C	Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway.	Nature cell biology	2006	97
17498290	1029	Le Maitre CL	Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration.	Arthritis research and therapy	2007	66
17890455	1029	Kawamata N	Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.	Blood	2008	57
18688285	1029	Hacein-Bey-Abina S	Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.	The Journal of clinical investigation	2008	456
18688286	1029	Howe SJ	Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.	The Journal of clinical investigation	2008	321
19485966	1029	Liu Y	Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging.	Aging cell	2009	74
20068183	1029	Schiffman JD	Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.	Cancer research	2010	86
21347436	1029	Koch CM	Specific age-associated DNA methylation changes in human dermal fibroblasts.	PloS one	2011	40
21559395	1029	von Levetzow C	Modeling initiation of Ewing sarcoma in human neural crest cells.	PloS one	2011	50
21636552	1029	Raabe EH	BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.	Clinical cancer research 	2011	42
21921043	1029	Hogan LE	Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.	Blood	2011	47
23373539	1029	Etchin J	KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.	British journal of haematology	2013	63
24005862	1029	Jin HJ	Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy.	International journal of molecular sciences	2013	66
24957142	1029	Moorman AV	A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia.	Blood	2014	24
25010205	1029	Brohl AS	The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.	PLoS genetics	2014	53
25223734	1029	Tirode F	Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.	Cancer discovery	2014	57
25890171	1029	Kong R	Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.	Molecular cancer	2015	26
27158978	1029	Kleeff J	Pancreatic cancer.	Nature reviews. Disease primers	2016	17
14726504	1050	Fröhling S	CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.	Journal of clinical oncology 	2004	80
16051734	1050	Döhner K	Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.	Blood	2005	140
16076867	1050	Schnittger S	Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.	Blood	2005	106
16109776	1050	Verhaak RG	Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.	Blood	2005	94
16936206	1050	Tchkonia T	Fat depot-specific characteristics are retained in strains derived from single human preadipocytes.	Diabetes	2006	69
18450602	1050	Schlenk RF	Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.	The New England journal of medicine	2008	304
18809607	1050	Marcucci G	Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.	Journal of clinical oncology 	2008	108
18838472	1050	Verhaak RG	Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.	Haematologica	2009	86
20038735	1050	Dufour A	Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.	Journal of clinical oncology 	2010	45
20368538	1050	Wagner K	Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.	Journal of clinical oncology 	2010	55
21177436	1050	Taskesen E	Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity.	Blood	2011	47
21220605	1050	Burnett A	Therapeutic advances in acute myeloid leukemia.	Journal of clinical oncology 	2011	128
21881046	1050	Shen Y	Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia.	Blood	2011	63
22417203	1050	Patel JP	Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.	The New England journal of medicine	2012	352
22987078	1050	Mrózek K	Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.	Journal of clinical oncology 	2012	75
24487413	1050	Kihara R	Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients.	Leukemia	2014	34
7507342	1080	Cozens AL	CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells.	American journal of respiratory cell and molecular biology	1994	211
9580754	1080	Rosenstein BJ	The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.	The Journal of pediatrics	1998	114
9725921	1080	Sharer N	Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.	The New England journal of medicine	1998	112
9725922	1080	Cohn JA	Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.	The New England journal of medicine	1998	103
12606185	1080	Ratjen F	Cystic fibrosis.	Lancet	2003	156
14534336	1080	Wilschanski M	Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.	The New England journal of medicine	2003	96
15105504	1080	Egan ME	Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects.	Science	2004	97
15716351	1080	Kreda SM	Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia.	Molecular biology of the cell	2005	75
16207846	1080	Drumm ML	Genetic modifiers of lung disease in cystic fibrosis.	The New England journal of medicine	2005	120
17332481	1080	Vanscoy LL	Heritability of lung disease severity in cystic fibrosis.	American journal of respiratory and critical care medicine	2007	58
18639722	1080	Farrell PM	Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.	The Journal of pediatrics	2008	150
18675692	1080	Quinton PM	Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis.	Lancet	2008	82
18722008	1080	Kerem E	Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.	Lancet	2008	88
20585638	1080	Cox MJ	Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.	PloS one	2010	114
20622026	1080	Meyerholz DK	Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children.	American journal of respiratory and critical care medicine	2010	59
20622033	1080	Sermet-Gaudelus I	Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.	American journal of respiratory and critical care medicine	2010	54
20711182	1080	Luciani A	Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition.	Nature cell biology	2010	116
21825083	1080	Clancy JP	Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.	Thorax	2012	115
22047557	1080	Ramsey BW	A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.	The New England journal of medicine	2011	270
22383668	1080	Flume PA	Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation.	Chest	2012	42
22427236	1080	Rosendahl J	CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated?	Gut	2013	40
22481418	1080	Cohen TS	Cystic fibrosis: a mucosal immunodeficiency syndrome.	Nature medicine	2012	95
23590265	1080	Davies JC	Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.	American journal of respiratory and critical care medicine	2013	44
23704228	1080	Cohen-Cymberknoh M	Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.	Thorax	2013	29
23727931	1080	Dekkers JF	A functional CFTR assay using primary cystic fibrosis intestinal organoids.	Nature medicine	2013	86
24925916	1080	Mall MA	CFTR: cystic fibrosis and beyond.	The European respiratory journal	2014	26
24927234	1080	Rowe SM	Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.	American journal of respiratory and critical care medicine	2014	54
24973281	1080	Boyle MP	A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.	The Lancet. Respiratory medicine	2014	52
25101886	1080	Cholon DM	Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis.	Science translational medicine	2014	54
25350163	1080	De Stefano D	Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.	Autophagy	2014	29
25917910	1080	Filkins LM	Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model.	Journal of bacteriology	2015	29
25981758	1080	Wainwright CE	Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.	The New England journal of medicine	2015	89
26070913	1080	Moss RB	Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.	The Lancet. Respiratory medicine	2015	23
26115565	1080	Mall MA	Targeting ion channels in cystic fibrosis.	Journal of cystic fibrosis 	2015	20
26149841	1080	Alton EWFW	Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.	The Lancet. Respiratory medicine	2015	27
26167630	1080	Ogawa M	Directed differentiation of cholangiocytes from human pluripotent stem cells.	Nature biotechnology	2015	19
26417704	1080	Corvol H	Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.	Nature communications	2015	24
26823392	1080	Veit G	From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations.	Molecular biology of the cell	2016	19
27320041	1080	Mou H	Dual SMAD Signaling Inhibition Enables Long-Term Expansion of Diverse Epithelial Basal Cells.	Cell stem cell	2016	14
15637236	1234	Gonzalez E	The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.	Science	2005	400
19692480	1234	Johnston SH	A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains.	Journal of virology	2009	47
20147895	1234	Saba E	HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model.	Mucosal immunology	2010	57
20410263	1234	Tu W	Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.	Journal of virology	2010	68
22002519	1234	Sun X	Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression.	Breast cancer research and treatment	2012	35
23043157	1234	Shaw GM	HIV transmission.	Cold Spring Harbor perspectives in medicine	2012	57
24129241	1234	Bedognetti D	CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.	British journal of cancer	2013	25
24652495	1234	Mitchell CM	Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells.	The Journal of infectious diseases	2014	21
25517468	1234	Mandal PK	Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9.	Cell stem cell	2014	72
26424571	1234	Sather BD	Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template.	Science translational medicine	2015	36
14702260	1312	Diamond A	Genetic and neurochemical modulation of prefrontal cognitive functions in children.	The American journal of psychiatry	2004	78
15157710	1312	Kim H	Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament.	Pain	2004	78
15537663	1312	Diatchenko L	Genetic basis for individual variations in pain perception and the development of a chronic pain condition.	Human molecular genetics	2005	245
15866551	1312	Caspi A	Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.	Biological psychiatry	2005	220
16043133	1312	Bruder GE	Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations.	Biological psychiatry	2005	74
16837133	1312	Diatchenko L	Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli.	Pain	2006	96
16917939	1312	James SJ	Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2006	115
17403981	1312	Gothelf D	Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.	The American journal of psychiatry	2007	64
17913879	1312	Frank MJ	Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning.	Proceedings of the National Academy of Sciences of the United States of America	2007	163
18057197	1312	Tan HY	Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory.	The Journal of neuroscience 	2007	56
18497887	1312	Tan HY	Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans.	The Journal of clinical investigation	2008	55
19210038	1312	Raz N	Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.	Neuropsychology	2009	48
19898482	1312	Ross CJ	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	Nature genetics	2009	56
19944409	1312	Kolassa IT	The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-o-methyltransferase Val(158)Met polymorphism.	Biological psychiatry	2010	64
20736997	1312	Paloyelis Y	DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls.	Neuropsychopharmacology 	2010	51
21610500	1312	Schmidt RJ	Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism.	Epidemiology	2011	58
22364739	1312	Farrell SM	COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition.	Biological psychiatry	2012	33
22487033	1312	Collins AG	How much of reinforcement learning is working memory, not reinforcement learning? A behavioral, computational, and neurogenetic analysis.	The European journal of neuroscience	2012	39
22815523	1312	Stice E	Multilocus genetic composite reflecting dopamine signaling capacity predicts reward circuitry responsivity.	The Journal of neuroscience 	2012	44
23303064	1312	Hart AB	Candidate gene studies of a promising intermediate phenotype: failure to replicate.	Neuropsychopharmacology 	2013	28
23632726	1312	Wachman EM	Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome.	JAMA	2013	28
24512061	1312	Lin H	Living in the moment: effects of time perspective and emotional valence of episodic thinking on delay discounting.	Behavioral neuroscience	2014	25
6367724	1351	Klein R	The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.	Archives of ophthalmology	1984	196
7977430	1351	Mazzaferri EL	Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.	The American journal of medicine	1994	236
8673487	1351	Starr A	Auditory neuropathy.	Brain 	1996	135
9414327	1351	Annegers JF	A population-based study of seizures after traumatic brain injuries.	The New England journal of medicine	1998	122
10387937	1351	Socié G	Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.	The New England journal of medicine	1999	104
12791877	1351	Jones N	Multilocus sequence typing system for group B streptococcus.	Journal of clinical microbiology	2003	151
16418464	1351	O'Connell KA	Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.	JAMA	2006	74
16790697	1351	Winer RL	Condom use and the risk of genital human papillomavirus infection in young women.	The New England journal of medicine	2006	105
17349844	1351	Shah SA	Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.	Surgery	2007	66
18315614	1351	Nichols WL	von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).	Haemophilia 	2008	83
18596250	1351	Terracciano A	Personality predictors of longevity: activity, emotional stability, and conscientiousness.	Psychosomatic medicine	2008	64
19797344	1351	Gunnell D	Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.	BMJ	2009	50
20660554	1351	Barlow KM	Epidemiology of postconcussion syndrome in pediatric mild traumatic brain injury.	Pediatrics	2010	43
22227284	1351	Chau JY	Cross-sectional associations between occupational and leisure-time sitting, physical activity and obesity in working adults.	Preventive medicine	2012	55
23323899	1351	Gouw SC	Factor VIII products and inhibitor development in severe hemophilia A.	The New England journal of medicine	2013	36
23382293	1351	Idilman IS	Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.	Radiology	2013	29
25609685	1351	Marko MK	Behavioural and neural basis of anomalous motor learning in children with autism.	Brain 	2015	15
26315980	1351	Sarpal DK	Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment.	The American journal of psychiatry	2016	14
26527675	1351	Kollman C	The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.	Blood	2016	14
27074389	1351	Twig G	Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood.	The New England journal of medicine	2016	21
17032921	1378	Fielding AK	Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.	Blood	2007	121
17213292	1378	Cornelissen JJ	Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?	Blood	2007	68
19706886	1378	Verneris MR	Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.	Blood	2009	75
23535063	1378	Zhu HH	MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial.	Blood	2013	26
23847197	1378	Walter RB	Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.	Blood	2013	38
25778476	1378	Jun G	A novel Alzheimer disease locus located near the gene encoding tau protein.	Molecular psychiatry	2016	23
25940714	1378	Wang Y	Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study.	Blood	2015	23
1538563	1392	Chrousos GP	The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.	JAMA	1992	380
9854171	1392	Arborelius L	The role of corticotropin-releasing factor in depression and anxiety disorders.	The Journal of endocrinology	1999	215
10918705	1392	Heim C	Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood.	JAMA	2000	316
11041447	1392	Challis JRG	Endocrine and paracrine regulation of birth at term and preterm.	Endocrine reviews	2000	153
11282691	1392	Heim C	Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse.	The American journal of psychiatry	2001	131
11430844	1392	Heim C	The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies.	Biological psychiatry	2001	456
11689280	1392	Weinstock M	Alterations induced by gestational stress in brain morphology and behaviour of the offspring.	Progress in neurobiology	2001	102
14728093	1392	Nemeroff CB	Neurobiological consequences of childhood trauma.	The Journal of clinical psychiatry	2004	90
15507922	1392	Wadhwa PD	Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation.	American journal of obstetrics and gynecology	2004	81
15914534	1392	Ilias I	Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health.	The Journal of clinical endocrinology and metabolism	2005	79
15919579	1392	Wadhwa PD	Psychoneuroendocrine processes in human pregnancy influence fetal development and health.	Psychoneuroendocrinology	2005	83
15920504	1392	Plotsky PM	Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring.	Neuropsychopharmacology 	2005	124
16124836	1392	Nemeroff CB	The neurobiology of depression: inroads to treatment and new drug discovery.	The Journal of clinical psychiatry	2005	72
17825799	1392	Heim C	The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma.	Biological psychiatry	2008	64
18334580	1392	Nieman LK	The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.	The Journal of clinical endocrinology and metabolism	2008	148
18339361	1392	Tyrka AR	Childhood parental loss and adult hypothalamic-pituitary-adrenal function.	Biological psychiatry	2008	62
18602762	1392	Heim C	The link between childhood trauma and depression: insights from HPA axis studies in humans.	Psychoneuroendocrinology	2008	258
18991954	1392	Sinha R	Chronic stress, drug use, and vulnerability to addiction.	Annals of the New York Academy of Sciences	2008	288
19363098	1392	Kramer MS	Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones.	American journal of epidemiology	2009	64
19406581	1392	Lopez-Duran NL	Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis.	Psychoneuroendocrinology	2009	75
19571587	1392	Papadimitriou A	Regulation of the hypothalamic-pituitary-adrenal axis.	Neuroimmunomodulation	2009	47
21257974	1392	Stetler C	Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.	Psychosomatic medicine	2011	116
22885871	1392	Burkett JP	The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.	Psychopharmacology	2012	43
24495607	1392	Belvederi Murri M	HPA axis and aging in depression: systematic review and meta-analysis.	Psychoneuroendocrinology	2014	23
7934491	1401	Elliott MJ	Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.	Lancet	1994	216
9870876	1401	Bresnihan B	Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.	Arthritis and rheumatism	1998	137
11744348	1401	Das UN	Is obesity an inflammatory condition?	Nutrition	2001	122
12510039	1401	Ghosh S	Natalizumab for active Crohn's disease.	The New England journal of medicine	2003	113
12555298	1401	McMillan DC	Systemic inflammatory response predicts survival following curative resection of colorectal cancer.	The British journal of surgery	2003	82
15136311	1401	Ford DE	Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey.	Archives of internal medicine	2004	94
15175438	1401	Weiss R	Obesity and the metabolic syndrome in children and adolescents.	The New England journal of medicine	2004	476
15234425	1401	Chrysohoou C	Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study.	Journal of the American College of Cardiology	2004	90
15307030	1401	Simon L	Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.	Clinical infectious diseases 	2004	183
15517647	1401	Wallace CA	Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.	The Journal of rheumatology	2004	81
15897982	1401	Carlson CS	Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels.	American journal of human genetics	2005	89
16043984	1401	Solem CA	Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.	Inflammatory bowel diseases	2005	73
16170078	1401	Emsley HC	A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients.	Journal of neurology, neurosurgery, and psychiatry	2005	109
16508926	1401	Smolen JS	Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.	Arthritis and rheumatism	2006	83
16735679	1401	Kobayashi T	Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.	Circulation	2006	66
16931170	1401	Maser EA	Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.	Clinical gastroenterology and hepatology 	2006	82
16980117	1401	Agranoff D	Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum.	Lancet	2006	62
17225957	1401	Pollitt RA	Early-life and adult socioeconomic status and inflammatory risk markers in adulthood.	European journal of epidemiology	2007	62
17229839	1401	Danese A	Childhood maltreatment predicts adult inflammation in a life-course study.	Proceedings of the National Academy of Sciences of the United States of America	2007	221
17310862	1401	Punjabi NM	C-reactive protein is associated with sleep disordered breathing independent of adiposity.	Sleep	2007	59
17341558	1401	Balagopal P	Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation.	The Journal of clinical endocrinology and metabolism	2007	61
17470699	1401	Ford ES	Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents.	Circulation	2007	90
17634458	1401	Sandborn WJ	Certolizumab pegol for the treatment of Crohn's disease.	The New England journal of medicine	2007	129
17634459	1401	Schreiber S	Maintenance therapy with certolizumab pegol for Crohn's disease.	The New England journal of medicine	2007	121
17916108	1401	Langhorst J	Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.	The American journal of gastroenterology	2008	96
17947302	1401	Lequerré T	Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.	Annals of the rheumatic diseases	2008	64
17997848	1401	Armah HB	Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children.	Malaria journal	2007	76
18054554	1401	Fraser A	Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.	Gastroenterology	2007	73
18276939	1401	Gozal D	Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children.	American journal of respiratory and critical care medicine	2008	99
18358927	1401	Yokota S	Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.	Lancet	2008	95
18391129	1401	Danese A	Elevated inflammation levels in depressed adults with a history of childhood maltreatment.	Archives of general psychiatry	2008	126
18566104	1401	Henriksen M	C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.	Gut	2008	52
18571548	1401	Tremoulet AH	Resistance to intravenous immunoglobulin in children with Kawasaki disease.	The Journal of pediatrics	2008	56
19054820	1401	Mukhtyar C	Modification and validation of the Birmingham Vasculitis Activity Score (version 3).	Annals of the rheumatic diseases	2009	54
19387353	1401	Triant VA	Association of C-reactive protein and HIV infection with acute myocardial infarction.	Journal of acquired immune deficiency syndromes	2009	99
19406957	1401	Zaritsky J	Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.	Clinical journal of the American Society of Nephrology 	2009	53
19407273	1401	Fernandez-Egea E	Metabolic profile of antipsychotic-naive individuals with non-affective psychosis.	The British journal of psychiatry 	2009	52
19524346	1401	Gruenewald TL	Association of socioeconomic status with inflammation markers in black and white men and women in the Coronary Artery Risk Development in Young Adults (CARDIA) study.	Social science and medicine	2009	53
19584191	1401	Nadeau KJ	Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity.	The Journal of clinical endocrinology and metabolism	2009	46
19725248	1401	Aran A	Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset.	Sleep	2009	57
19820018	1401	Smith J	Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity.	The Journal of clinical endocrinology and metabolism	2009	58
19966092	1401	Ford AL	What reduction in BMI SDS is required in obese adolescents to improve body composition and cardiometabolic health?	Archives of disease in childhood	2010	41
19995479	1401	Sutin AR	High neuroticism and low conscientiousness are associated with interleukin-6.	Psychological medicine	2010	51
20194272	1401	Skinner AC	Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood.	Pediatrics	2010	50
20421924	1401	Whincup PH	Early emergence of ethnic differences in type 2 diabetes precursors in the UK: the Child Heart and Health Study in England (CHASE Study).	PLoS medicine	2010	40
20516377	1401	Fraser A	Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood.	Circulation	2010	107
20610634	1401	Thurnham DI	Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis.	The American journal of clinical nutrition	2010	82
20627925	1401	Nguyen-Van-Tam JS	Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).	Thorax	2010	57
21062445	1401	Hagau N	Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.	Critical care	2010	57
21173013	1401	Quartier P	A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).	Annals of the rheumatic diseases	2011	74
21279990	1401	Genovese MC	An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.	Arthritis and rheumatism	2011	51
21324198	1401	Koch A	Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.	Critical care	2011	50
21364762	1401	Erdman LK	Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study.	PloS one	2011	48
21534675	1401	Shankar A	Loneliness, social isolation, and behavioral and biological health indicators in older adults.	Health psychology 	2011	52
21542910	1401	Carson V	Volume, patterns, and types of sedentary behavior and cardio-metabolic health in children and adolescents: a cross-sectional study.	BMC public health	2011	44
21653621	1401	Van den Bruel A	Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review.	BMJ	2011	40
21791456	1401	Andersen LB	Physical activity and cardiovascular risk factors in children.	British journal of sports medicine	2011	41
21792295	1401	Kones R	Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.	Drug design, development and therapy	2011	39
22158726	1401	Duncan A	Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements.	The American journal of clinical nutrition	2012	34
22228627	1401	Prentice AM	Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children.	Blood	2012	44
22237992	1401	Satoh M	Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.	Arthritis and rheumatism	2012	50
22294344	1401	Sibley CH	Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.	Arthritis and rheumatism	2012	44
22405251	1401	Kobayashi T	Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.	Lancet	2012	38
22494534	1401	Miller GE	Clustering of depression and inflammation in adolescents previously exposed to childhood adversity.	Biological psychiatry	2012	51
22727478	1401	Slopen N	Childhood adversity and inflammatory processes in youth: a prospective study.	Psychoneuroendocrinology	2013	42
22738663	1401	Yan S	The expanding burden of cardiometabolic risk in China: the China Health and Nutrition Survey.	Obesity reviews 	2012	40
22752869	1401	Eyre DW	Predictors of first recurrence of Clostridium difficile infection: implications for initial management.	Clinical infectious diseases 	2012	34
23022122	1401	DeBoer MD	Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions.	Nutrition	2013	34
23089630	1401	Lamers F	Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression.	Molecular psychiatry	2013	65
23129601	1401	Ridker PM	Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial.	Circulation	2012	76
23141484	1401	Yamamoto S	Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.	Journal of the American College of Cardiology	2012	37
23171381	1401	Choi J	Obesity and C-reactive protein in various populations: a systematic review and meta-analysis.	Obesity reviews 	2013	69
23252526	1401	Ruperto N	Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.	The New England journal of medicine	2012	69
23264288	1401	Wang X	Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis.	Diabetes care	2013	74
23500256	1401	Khoury M	Role of the waist/height ratio in the cardiometabolic risk assessment of children classified by body mass index.	Journal of the American College of Cardiology	2013	26
23612048	1401	Vogelzangs N	Anxiety disorders and inflammation in a large adult cohort.	Translational psychiatry	2013	49
23687260	1401	Yoo DH	A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study.	Annals of the rheumatic diseases	2013	57
23769296	1401	McInnes IB	Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.	Lancet	2013	59
23842110	1401	Groeger D	Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.	Gut microbes	2013	28
24185532	1401	Shah BA	Neonatal sepsis: an old problem with new insights.	Virulence	2014	26
24205846	1401	Coelho R	Childhood maltreatment and inflammatory markers: a systematic review.	Acta psychiatrica Scandinavica	2014	28
24396135	1401	Simonsen KA	Early-onset neonatal sepsis.	Clinical microbiology reviews	2014	49
24429405	1401	Sinha A	Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.	Kidney international	2014	21
24474383	1401	Cornillie F	Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial.	Gut	2014	37
24553386	1401	Davila ML	Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.	Science translational medicine	2014	297
24558364	1401	Prendergast AJ	Stunting is characterized by chronic inflammation in Zimbabwean infants.	PloS one	2014	41
24695951	1401	Simeone E	Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.	Cancer immunology, immunotherapy 	2014	28
25133871	1401	Khandaker GM	Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study.	JAMA psychiatry	2014	49
25274000	1401	Xanthakis V	Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study.	Circulation	2014	24
25517597	1401	Kopylov U	Small bowel capsule endoscopy in the management of established Crohn's disease: clinical impact, safety, and correlation with inflammatory biomarkers.	Inflammatory bowel diseases	2015	21
25527668	1401	Karakochuk CD	Genetic hemoglobin disorders rather than iron deficiency are a major predictor of hemoglobin concentration in women of reproductive age in rural prey Veng, Cambodia.	The Journal of nutrition	2015	16
25557209	1401	Karachaliou M	Association of trimester-specific gestational weight gain with fetal growth, offspring obesity, and cardiometabolic traits in early childhood.	American journal of obstetrics and gynecology	2015	20
25647155	1401	Suskind DL	Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.	Inflammatory bowel diseases	2015	21
25965853	1401	Dopico XC	Widespread seasonal gene expression reveals annual differences in human immunity and physiology.	Nature communications	2015	40
26084991	1401	Zhou T	Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer.	Scientific reports	2015	18
26271406	1401	Hunt L	Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.	The Lancet. Infectious diseases	2015	32
26729882	1401	Yang YC	Social relationships and physiological determinants of longevity across the human life span.	Proceedings of the National Academy of Sciences of the United States of America	2016	15
28615259	1401	Namaste SM	Adjusting ferritin concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project.	The American journal of clinical nutrition	2017	6
8931596	1437	Reiss AL	Brain development, gender and IQ in children. A volumetric imaging study.	Brain 	1996	165
10234034	1437	Gur RC	Sex differences in brain gray and white matter in healthy young adults: correlations with cognitive performance.	The Journal of neuroscience 	1999	134
11160266	1437	Goriely S	Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes.	Journal of immunology	2001	88
11811649	1437	Sowell ER	Development of cortical and subcortical brain structures in childhood and adolescence: a structural MRI study.	Developmental medicine and child neurology	2002	170
12952922	1437	Doran KS	Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis.	The Journal of clinical investigation	2003	76
16783192	1437	Finnerty CC	Cytokine expression profile over time in severely burned pediatric patients.	Shock	2006	72
17965776	1437	Thorne SH	Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963.	The Journal of clinical investigation	2007	65
18202348	1437	Inoue Y	Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.	American journal of respiratory and critical care medicine	2008	50
18292469	1437	O'Reilly MA	Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus.	American journal of respiratory and critical care medicine	2008	53
18578883	1437	Bozza FA	Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity.	BMC infectious diseases	2008	93
18761410	1437	Altaye M	Infant brain probability templates for MRI segmentation and normalization.	NeuroImage	2008	51
19157572	1437	Li X	Elevated immune response in the brain of autistic patients.	Journal of neuroimmunology	2009	132
19609242	1437	Weide B	Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.	Journal of immunotherapy	2009	45
19666104	1437	Enstrom AM	Differential monocyte responses to TLR ligands in children with autism spectrum disorders.	Brain, behavior, and immunity	2010	73
20017188	1437	Scriba TJ	Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.	European journal of immunology	2010	67
20030565	1437	Frugier T	In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury.	Journal of neurotrauma	2010	55
20664527	1437	Koski A	Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.	Molecular therapy 	2010	69
20833247	1437	Ashwood P	Altered T cell responses in children with autism.	Brain, behavior, and immunity	2011	60
20879881	1437	Yu AL	Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.	The New England journal of medicine	2010	283
21153402	1437	Hall MW	Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome.	Intensive care medicine	2011	53
22271649	1437	Sharkey DJ	Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus.	Journal of immunology	2012	60
22913682	1437	Browne SK	Adult-onset immunodeficiency in Thailand and Taiwan.	The New England journal of medicine	2012	73
23493351	1437	Kanerva A	Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus.	Clinical cancer research 	2013	42
24643864	1437	Saijo T	Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.	mBio	2014	30
24667615	1437	Walko TD 3rd	Cerebrospinal fluid mitochondrial DNA: a novel DAMP in pediatric traumatic brain injury.	Shock	2014	20
11172139	1440	Bensinger WI	Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.	The New England journal of medicine	2001	99
12791654	1440	Maris MB	HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.	Blood	2003	79
15753458	1440	Aversa F	Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.	Journal of clinical oncology 	2005	119
15890685	1440	Flomenberg N	The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.	Blood	2005	87
17227995	1440	Lewis IJ	Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.	Journal of the National Cancer Institute	2007	57
17426276	1440	Voltarelli JC	Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.	JAMA	2007	103
18637092	1440	Pai M	Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis.	The American journal of gastroenterology	2008	51
19363221	1440	DiPersio JF	Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.	Blood	2009	104
20007560	1440	Hsieh MM	Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.	The New England journal of medicine	2009	79
21172891	1440	Burnett AK	Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial.	Journal of clinical oncology 	2011	103
22119930	1440	Garg V	Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure.	Gastroenterology	2012	41
22828446	1440	Mougiakakos D	Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.	Leukemia	2013	27
22841419	1440	Elliott MJ	Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study.	Lancet	2012	55
23165479	1440	Di Bartolomeo P	Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies.	Blood	2013	33
23963331	1440	Ringelstein EB	Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial.	Stroke	2013	28
25500887	1440	Haller MJ	Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes.	The Journal of clinical investigation	2015	18
15607309	1471	Filler G	Cystatin C as a marker of GFR--history, indications, and future research.	Clinical biochemistry	2005	111
15961546	1471	Grubb A	Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children.	Clinical chemistry	2005	72
17329575	1471	Perkins BA	Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.	Journal of the American Society of Nephrology 	2007	105
17699320	1471	Furth SL	Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study.	Clinical journal of the American Society of Nephrology 	2006	104
18235143	1471	Baxmann AC	Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C.	Clinical journal of the American Society of Nephrology 	2008	74
19158356	1471	Schwartz GJ	New equations to estimate GFR in children with CKD.	Journal of the American Society of Nephrology 	2009	343
19820136	1471	Schwartz GJ	Measurement and estimation of GFR in children and adolescents.	Clinical journal of the American Society of Nephrology 	2009	71
20332356	1471	Ficociello LH	High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.	Diabetes care	2010	43
21601330	1471	Zhang Z	Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis.	American journal of kidney diseases 	2011	43
22622496	1471	Schwartz GJ	Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C.	Kidney international	2012	49
25554404	1471	Raman SV	Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.	The Lancet. Neurology	2015	26
11722623	1493	Shevach EM	Control of T-cell activation by CD4+ CD25+ suppressor T cells.	Immunological reviews	2001	98
14604957	1493	Marshall NA	Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma.	Blood	2004	90
15034022	1493	Munn DH	Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.	Journal of immunology	2004	109
15128835	1493	de Kleer IM	CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.	Journal of immunology	2004	78
19130927	1493	Shreffler WG	Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein.	The Journal of allergy and clinical immunology	2009	45
20220088	1493	Allen CE	Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.	Journal of immunology	2010	43
23466307	1493	Sangro B	A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.	Journal of hepatology	2013	80
23922369	1493	Gautam S	CD8 T cell exhaustion in human visceral leishmaniasis.	The Journal of infectious diseases	2014	29
23960017	1493	Han Y	Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.	Hepatology	2014	26
24045166	1493	Kmiecik J	Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level.	Journal of neuroimmunology	2013	32
25213377	1493	Kuehn HS	Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.	Science	2014	83
25634360	1493	Rosenzwajg M	Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.	Journal of autoimmunity	2015	24
26206937	1493	Lo B	AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.	Science	2015	32
26258847	1493	Ungewickell A	Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.	Nature genetics	2015	27
26927206	1493	Baumeister SH	Coinhibitory Pathways in Immunotherapy for Cancer.	Annual review of immunology	2016	27
16258095	1499	Ellison DW	beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.	Journal of clinical oncology 	2005	68
17576928	1499	Kwon C	Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors.	Proceedings of the National Academy of Sciences of the United States of America	2007	96
18322101	1499	Leng Y	Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.	The Journal of neuroscience 	2008	57
18697834	1499	Otto A	Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration.	Journal of cell science	2008	66
18769486	1499	Kool M	Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.	PloS one	2008	203
19061838	1499	Cairo S	Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.	Cancer cell	2008	56
19197950	1499	Fattet S	Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.	The Journal of pathology	2009	50
19718039	1499	Lancaster MA	Impaired Wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy.	Nature medicine	2009	66
20921458	1499	Ellison DW	Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.	Journal of clinical oncology 	2011	63
21636786	1499	Gaston-Massuet C	Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans.	Proceedings of the National Academy of Sciences of the United States of America	2011	41
21821917	1499	Alastalo TP	Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival.	The Journal of clinical investigation	2011	53
22142829	1499	Shukla N	Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways.	Clinical cancer research 	2012	62
22820256	1499	Pugh TJ	Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.	Nature	2012	203
24413733	1499	Brastianos PK	Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.	Nature genetics	2014	36
24436047	1499	Shern JF	Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.	Cancer discovery	2014	82
24614104	1499	Tucci V	Dominant β-catenin mutations cause intellectual disability with recognizable syndromic features.	The Journal of clinical investigation	2014	26
24706870	1499	Chen EY	Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.	Proceedings of the National Academy of Sciences of the United States of America	2014	26
24837480	1499	Tao J	Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.	Gastroenterology	2014	34
25490274	1499	Juhlin CC	Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.	The Journal of clinical endocrinology and metabolism	2015	17
25848746	1499	D'Uva G	ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.	Nature cell biology	2015	56
27378147	1499	Marchetto MC	Altered proliferation and networks in neural cells derived from idiopathic autistic individuals.	Molecular psychiatry	2017	12
10857554	1589	White PC	Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.	Endocrine reviews	2000	119
20823466	1589	Speiser PW	Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.	The Journal of clinical endocrinology and metabolism	2010	115
11784456	1613	Stall R	Alcohol use, drug use and alcohol-related problems among men who have sex with men: the Urban Men's Health Study.	Addiction	2001	168
12594195	1613	Krieger N	Choosing area based socioeconomic measures to monitor social inequalities in low birth weight and childhood lead poisoning: The Public Health Disparities Geocoding Project (US).	Journal of epidemiology and community health	2003	171
16140349	1613	Sturm R	Body mass index in elementary school children, metropolitan area food prices and food outlet density.	Public health	2005	87
17071283	1613	Whitney CG	Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.	Lancet	2006	98
18593774	1628	Engelman CD	Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans.	The Journal of clinical endocrinology and metabolism	2008	76
19144222	1628	Stroud LR	Stress response and the adolescent transition: performance versus peer rejection stressors.	Development and psychopathology	2009	114
22247500	1628	Heijboer AC	Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration.	Clinical chemistry	2012	34
23425703	1628	van de Vijver SJ	Prevalence, awareness, treatment and control of hypertension among slum dwellers in Nairobi, Kenya.	Journal of hypertension	2013	29
23509172	1628	Parkinson JR	Preterm birth and the metabolic syndrome in adult life: a systematic review and meta-analysis.	Pediatrics	2013	35
25775274	1628	Beveridge LA	Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data.	JAMA internal medicine	2015	35
27250744	1628	Denburg MR	Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes.	Journal of bone and mineral research 	2016	11
9217756	1636	-	Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)	Lancet	1997	153
10553792	1636	Anda RF	Adverse childhood experiences and smoking during adolescence and adulthood.	JAMA	1999	184
10752702	1636	-	Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group.	Lancet	2000	96
11566918	1636	London GM	Arterial wave reflections and survival in end-stage renal failure.	Hypertension	2001	109
12612237	1636	Dube SR	Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study.	Pediatrics	2003	207
12788992	1636	Perkins BA	Regression of microalbuminuria in type 1 diabetes.	The New England journal of medicine	2003	147
12914833	1636	Dube SR	The impact of adverse childhood experiences on health problems: evidence from four birth cohorts dating back to 1900.	Preventive medicine	2003	117
13678869	1636	McMurray JJ	Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.	Lancet	2003	157
15076798	1636	Pescatello LS	American College of Sports Medicine position stand. Exercise and hypertension.	Medicine and science in sports and exercise	2004	182
15261471	1636	Dong M	The interrelatedness of multiple forms of childhood abuse, neglect, and household dysfunction.	Child abuse and neglect	2004	155
15381652	1636	Dong M	Insights into causal pathways for ischemic heart disease: adverse childhood experiences study.	Circulation	2004	176
15488250	1636	Chapman DP	Adverse childhood experiences and the risk of depressive disorders in adulthood.	Journal of affective disorders	2004	218
15766995	1636	Ruggenenti P	Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.	Lancet	2005	83
16549308	1636	Dube SR	Adverse childhood experiences and the association with ever using alcohol and initiating alcohol use during adolescence.	The Journal of adolescent health 	2006	107
16760444	1636	Cooper WO	Major congenital malformations after first-trimester exposure to ACE inhibitors.	The New England journal of medicine	2006	115
19840693	1636	Brown DW	Adverse childhood experiences and the risk of premature mortality.	American journal of preventive medicine	2009	81
19846849	1636	ESCAPE Trial Group.	Strict blood-pressure control and progression of renal failure in children.	The New England journal of medicine	2009	100
20625111	1636	Hsu DT	Enalapril in infants with single ventricle: results of a multicenter randomized trial.	Circulation	2010	43
22158026	1636	Shiina S	Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.	The American journal of gastroenterology	2012	89
22166847	1636	Gross O	Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy.	Kidney international	2012	35
25203083	1636	Yawn BP	Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.	JAMA	2014	110
25300735	1636	Gilbert LK	Childhood adversity and adult chronic disease: an update from ten states and the District of Columbia, 2010.	American journal of preventive medicine	2015	18
25399731	1636	Torres VE	Angiotensin blockade in late autosomal dominant polycystic kidney disease.	The New England journal of medicine	2014	25
14707860	1674	Folpe AL	Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.	The American journal of surgical pathology	2004	76
15613856	1674	Miettinen M	Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.	The American journal of surgical pathology	2005	174
16327428	1674	Folpe AL	Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.	The American journal of surgical pathology	2005	106
16720851	1674	Bernstein M	Ewing's sarcoma family of tumors: current management.	The oncologist	2006	76
21388673	1674	Raya-Rivera A	Tissue-engineered autologous urethras for patients who need reconstruction: an observational study.	Lancet	2011	53
2491009	1756	Koenig M	The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.	American journal of human genetics	1989	169
3282674	1756	Koenig M	The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.	Cell	1988	298
3384440	1756	Monaco AP	An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.	Genomics	1988	218
9563954	1756	Olson TM	Actin mutations in dilated cardiomyopathy, a heritable form of heart failure.	Science	1998	110
11087833	1756	Sander M	Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy.	Proceedings of the National Academy of Sciences of the United States of America	2000	110
11121445	1756	Chen YW	Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology.	The Journal of cell biology	2000	128
12415109	1756	Haslett JN	Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle.	Proceedings of the National Academy of Sciences of the United States of America	2002	90
15867092	1756	Rodriguez AM	Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse.	The Journal of experimental medicine	2005	82
18160687	1756	van Deutekom JC	Local dystrophin restoration with antisense oligonucleotide PRO051.	The New England journal of medicine	2007	251
19713152	1756	Kinali M	Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.	The Lancet. Neurology	2009	200
20517298	1756	Kornegay JN	Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs.	Molecular therapy 	2010	57
20517938	1756	Malik V	Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.	Annals of neurology	2010	71
20925545	1756	Mendell JR	Dystrophin immunity in Duchenne's muscular dystrophy.	The New England journal of medicine	2010	149
21428760	1756	Goemans NM	Systemic administration of PRO051 in Duchenne's muscular dystrophy.	The New England journal of medicine	2011	225
21784508	1756	Cirak S	Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.	Lancet	2011	246
23521559	1756	Koo T	Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy.	Human gene therapy	2013	32
23907995	1756	Mendell JR	Eteplirsen for the treatment of Duchenne muscular dystrophy.	Annals of neurology	2013	111
24282529	1756	Zaharieva IT	Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.	PloS one	2013	27
24349052	1756	Finkel RS	Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy.	PloS one	2013	45
24434629	1756	Guan X	Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.	Stem cell research	2014	23
25042693	1756	Leung DG	Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy.	Annals of neurology	2014	21
25322757	1756	Mendell JR	A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.	Molecular therapy 	2015	34
25497400	1756	Haas M	European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene.	Neuromuscular disorders 	2015	20
25791035	1756	Lin B	Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.	Disease models and mechanisms	2015	19
25859012	1756	Chen Y	Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9.	Human molecular genetics	2015	30
26365034	1756	Ricotti V	Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations.	Developmental medicine and child neurology	2016	13
26543057	1756	Cossu G	Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy.	EMBO molecular medicine	2015	17
12773616	1815	Fan J	Mapping the genetic variation of executive attention onto brain activity.	Proceedings of the National Academy of Sciences of the United States of America	2003	83
16770765	1815	Bakermans-Kranenburg MJ	Gene-environment interaction of the dopamine D4 receptor (DRD4) and observed maternal insensitivity predicting externalizing behavior in preschoolers.	Developmental psychobiology	2006	76
17931433	1815	Sheese BE	Parenting quality interacts with genetic variation in dopamine receptor D4 to influence temperament in early childhood.	Development and psychopathology	2007	62
18194028	1815	Bakermans-Kranenburg MJ	Experimental evidence for differential susceptibility: dopamine D4 receptor polymorphism (DRD4 VNTR) moderates intervention effects on toddlers' externalizing behavior in a randomized controlled trial.	Developmental psychology	2008	90
10684852	1861	Arentz-Hansen H	The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.	The Journal of experimental medicine	2000	118
22432018	1861	Sellitto M	Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants.	PloS one	2012	46
1448077	2056	Semenza GL	A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.	Molecular and cellular biology	1992	431
2062846	2056	Semenza GL	Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.	Proceedings of the National Academy of Sciences of the United States of America	1991	144
8408001	2056	Wang GL	Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia.	The Journal of biological chemistry	1993	153
8897823	2056	Jiang BH	Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension.	The American journal of physiology	1996	222
12393428	2056	Weinstein DA	Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease.	Blood	2002	104
17488680	2056	Origa R	Liver iron concentrations and urinary hepcidin in beta-thalassemia.	Haematologica	2007	81
19410717	2056	Bohlius J	Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.	Lancet	2009	89
19651565	2056	Zhu C	Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy.	Pediatrics	2009	61
20105662	2056	Walker A	Breast milk as the gold standard for protective nutrients.	The Journal of pediatrics	2010	49
21127173	2056	England SJ	Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus.	Blood	2011	44
21900080	2056	Sachdev V	Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.	Circulation	2011	36
23008465	2056	Wu YW	Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.	Pediatrics	2012	46
23281216	2056	Min K	Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial.	Stem cells	2013	26
23502961	2056	Ramos P	Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia.	Nature medicine	2013	54
23617889	2056	Cavallaro G	The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge.	Acta ophthalmologica	2014	20
24366362	2056	Rumi E	JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.	Blood	2014	63
25157725	2056	Leuchter RH	Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age.	JAMA	2014	24
25218788	2056	Gordon SC	Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.	Journal of hepatology	2015	21
9360930	2120	Lacronique V	A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia.	Science	1997	164
12048236	2120	Mori H	Chromosome translocations and covert leukemic clones are generated during normal fetal development.	Proceedings of the National Academy of Sciences of the United States of America	2002	93
12086872	2120	Yeoh EJ	Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.	Cancer cell	2002	342
12730115	2120	Ross ME	Classification of pediatric acute lymphoblastic leukemia by gene expression profiling.	Blood	2003	128
15908956	2120	Castor A	Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.	Nature medicine	2005	67
18202291	2120	Hong D	Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.	Science	2008	94
18388178	2120	Borowitz MJ	Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.	Blood	2008	136
20409752	2120	Moorman AV	Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.	The Lancet. Oncology	2010	58
22162831	2120	Van Vlierberghe P	ETV6 mutations in early immature human T cell leukemias.	The Journal of experimental medicine	2011	49
24076604	2120	Jaffe JD	Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia.	Nature genetics	2013	62
24327398	2120	Leeman-Neill RJ	ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer.	Cancer	2014	25
16444271	2312	Smith FJ	Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris.	Nature genetics	2006	148
16550169	2312	Palmer CN	Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.	Nature genetics	2006	355
17512043	2312	Howell MD	Cytokine modulation of atopic dermatitis filaggrin skin expression.	The Journal of allergy and clinical immunology	2007	93
18325573	2312	Henderson J	The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study.	The Journal of allergy and clinical immunology	2008	61
18396323	2312	Weidinger S	Filaggrin mutations, atopic eczema, hay fever, and asthma in children.	The Journal of allergy and clinical immunology	2008	61
19733298	2312	Gao PS	Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum.	The Journal of allergy and clinical immunology	2009	45
25282568	2312	Brough HA	Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations.	The Journal of allergy and clinical immunology	2014	20
10216104	2322	Kiyoi H	Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.	Blood	1999	104
11535508	2322	Kottaridis PD	The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.	Blood	2001	208
12393388	2322	Fröhling S	Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.	Blood	2002	135
16912228	2322	Meshinchi S	Clinical implications of FLT3 mutations in pediatric AML.	Blood	2006	74
17957027	2322	Gale RE	The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.	Blood	2008	108
18187662	2322	Garzon R	MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.	Blood	2008	196
18716133	2322	Metzeler KH	An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.	Blood	2008	85
18840713	2322	Kornblau SM	Functional proteomic profiling of AML predicts response and survival.	Blood	2009	91
19047294	2322	Büchner T	Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.	Journal of clinical oncology 	2009	49
20212254	2322	Ravandi F	Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia.	Journal of clinical oncology 	2010	94
21079133	2322	Schwind S	Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.	Journal of clinical oncology 	2010	48
21127174	2322	Kayser S	The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.	Blood	2011	45
21148331	2322	Schnittger S	RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis.	Blood	2011	42
22291086	2322	Brunet S	Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.	Journal of clinical oncology 	2012	39
22627678	2322	Stone RM	Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia.	Leukemia	2012	47
22715121	2322	Iland HJ	All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).	Blood	2012	34
23321257	2322	Jourdan E	Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.	Blood	2013	32
25092144	2322	Gerloff D	NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia.	Leukemia	2015	18
25253770	2322	Irving J	Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.	Blood	2014	39
25270908	2322	Schlenk RF	Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation.	Blood	2014	26
25732155	2322	Chen X	Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.	Journal of clinical oncology 	2015	20
15608041	2332	Sullivan AK	Association of FMR1 repeat size with ovarian dysfunction.	Human reproduction	2005	115
16685180	2332	Farzin F	Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.	Journal of developmental and behavioral pediatrics 	2006	124
16700053	2332	Hatton DD	Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP.	American journal of medical genetics. Part A	2006	125
17074338	2332	Wittenberger MD	The FMR1 premutation and reproduction.	Fertility and sterility	2007	92
17618523	2332	Berry-Kravis E	Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines.	Movement disorders 	2007	92
17932962	2332	Gothelf D	Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP).	Annals of neurology	2008	73
18348275	2332	Coffey SM	Expanded clinical phenotype of women with the FMR1 premutation.	American journal of medical genetics. Part A	2008	117
18553360	2332	Roberts JE	Mood and anxiety disorders in females with the FMR1 premutation.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2009	98
18570292	2332	Bailey DB Jr	Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey.	American journal of medical genetics. Part A	2008	114
19422761	2332	Bourgeois JA	A review of fragile X premutation disorders: expanding the psychiatric perspective.	The Journal of clinical psychiatry	2009	79
19460941	2332	Fernandez-Carvajal I	Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population.	The Journal of molecular diagnostics 	2009	70
19804849	2332	Coffee B	Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA.	American journal of human genetics	2009	88
21796106	2332	Gross C	Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.	Neuropsychopharmacology 	2012	43
22001913	2332	Chonchaiya W	Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.	Human genetics	2012	46
22022567	2332	Sheridan SD	Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.	PloS one	2011	98
22149120	2332	Seltzer MM	Differential sensitivity to life stress in FMR1 premutation carrier mothers of children with fragile X syndrome.	Health psychology 	2012	37
22498846	2332	Yrigollen CM	AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome.	Genetics in medicine 	2012	34
22542183	2332	Iossifov I	De novo gene disruptions in children on the autistic spectrum.	Neuron	2012	414
22619118	2332	Seltzer MM	Prevalence of CGG expansions of the FMR1 gene in a US population-based sample.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2012	48
22993294	2332	Berry-Kravis EM	Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.	Science translational medicine	2012	99
23867198	2332	Hagerman R	Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.	The Lancet. Neurology	2013	85
24654675	2332	Doers ME	iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth.	Stem cells and development	2014	23
8815938	2395	Dürr A	Clinical and genetic abnormalities in patients with Friedreich's ataxia.	The New England journal of medicine	1996	129
21315377	2395	Koeppen AH	Friedreich's ataxia: pathology, pathogenesis, and molecular genetics.	Journal of the neurological sciences	2011	77
25159818	2395	Soragni E	Epigenetic therapy for Friedreich ataxia.	Annals of neurology	2014	23
16951235	2475	Yee KW	Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.	Clinical cancer research 	2006	69
17463046	2475	Roos S	Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth.	The Journal of physiology	2007	68
19103993	2475	Zhu W	Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway.	Circulation	2009	50
19201859	2475	Fernandez DR	Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.	Journal of immunology	2009	50
20096093	2475	Carlsen MH	The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide.	Nutrition journal	2010	57
20152770	2475	Balamuth NJ	Ewing's sarcoma.	The Lancet. Oncology	2010	92
21047224	2475	Krueger DA	Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.	The New England journal of medicine	2010	206
22268788	2475	Hoeffer CA	Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.	Genes, brain, and behavior	2012	46
22465830	2475	Naing A	Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumors.	Clinical cancer research 	2012	54
22685175	2475	Tasian SK	Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.	Blood	2012	42
22687819	2475	Jansson T	The emerging role of mTORC1 signaling in placental nutrient-sensing.	Placenta	2012	31
22734070	2475	Payne EM	L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.	Blood	2012	42
22919032	2475	McInturff AM	Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 α.	Blood	2012	43
23150676	2475	Jansson N	Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies.	The Journal of clinical endocrinology and metabolism	2013	43
23158522	2475	Franz DN	Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.	Lancet	2013	113
23165769	2475	Rosario FJ	Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells.	The Journal of physiology	2013	35
23255238	2475	Gorlick R	Children's Oncology Group's 2013 blueprint for research: bone tumors.	Pediatric blood and cancer	2013	29
24211184	2475	Yao S	Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation.	Immunity	2013	49
24249672	2475	Bagatell R	Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group Study.	Pediatric blood and cancer	2014	23
24556040	2475	Motzer RJ	Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.	The Lancet. Oncology	2014	48
24585383	2475	Scheffer IE	Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations.	Annals of neurology	2014	27
24632219	2475	Botter SM	Recent advances in osteosarcoma.	Current opinion in pharmacology	2014	31
25282103	2475	Wood AR	Defining the role of common variation in the genomic and biological architecture of adult human height.	Nature genetics	2014	268
25446280	2475	Wagner LM	Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group.	Pediatric blood and cancer	2015	17
25498219	2475	Grignani G	Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.	The Lancet. Oncology	2015	30
25512523	2475	Perry JA	Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.	Proceedings of the National Academy of Sciences of the United States of America	2014	46
25591831	2475	Curatolo P	Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.	Pediatric neurology	2015	15
25913192	2475	Venkatesh HS	Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.	Cell	2015	38
26018084	2475	Nakashima M	Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.	Annals of neurology	2015	19
26067126	2475	Curatolo P	Neurological and neuropsychiatric aspects of tuberous sclerosis complex.	The Lancet. Neurology	2015	29
26156073	2475	Bissler JJ	Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.	Nephrology, dialysis, transplantation 	2016	17
27613521	2475	French JA	Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.	Lancet	2016	13
16968913	2539	Hill DR	Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I.	The American journal of tropical medicine and hygiene	2006	87
17355169	2539	Guindo A	X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria.	PLoS medicine	2007	89
18177777	2539	Cappellini MD	Glucose-6-phosphate dehydrogenase deficiency.	Lancet	2008	225
18215251	2539	Vafa M	Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants.	Malaria journal	2008	62
18305266	2539	Calis JC	Severe anemia in Malawian children.	The New England journal of medicine	2008	88
18522503	2539	Clark TD	Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda.	The Journal of infectious diseases	2008	56
20194698	2539	Shekalaghe SA	In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.	Antimicrobial agents and chemotherapy	2010	47
21311583	2539	malERA Consultative Group on Diagnoses and Diagnostics.	A research agenda for malaria eradication: diagnoses and diagnostics.	PLoS medicine	2011	111
22940027	2539	Amaratunga C	Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.	The Lancet. Infectious diseases	2012	137
24239324	2539	Eziefula AC	Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.	The Lancet. Infectious diseases	2014	35
24360369	2539	Llanos-Cuentas A	Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.	Lancet	2014	67
24376273	2539	Rolling T	Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.	The Journal of infectious diseases	2014	23
27010542	2539	Bancone G	Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.	PloS one	2016	13
17151339	2548	Kishnani PS	Recombinant human acid alpha-glucosidase: major clinical benefits in infantile-onset Pompe disease.	Neurology	2007	141
19775921	2548	Kishnani PS	Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants.	Molecular genetics and metabolism	2010	81
20393176	2548	van der Ploeg AT	A randomized study of alglucosidase alfa in late-onset Pompe's disease.	The New England journal of medicine	2010	95
22237443	2548	Messinger YH	Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease.	Genetics in medicine 	2012	45
23570273	2548	Smith BK	Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes.	Human gene therapy	2013	36
26053072	2548	Su J	Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice.	Plant biotechnology journal	2015	17
8666144	2571	Verge CF	Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.	Diabetes	1996	131
9054945	2571	Pugliese A	The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.	Nature genetics	1997	162
15700048	2571	Rapoport JL	The neurodevelopmental model of schizophrenia: update 2005.	Molecular psychiatry	2005	201
18843118	2571	Ludvigsson J	GAD treatment and insulin secretion in recent-onset type 1 diabetes.	The New England journal of medicine	2008	123
20437582	2571	Malter MP	Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.	Annals of neurology	2010	62
21714999	2571	Wherrett DK	Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.	Lancet	2011	77
21795557	2571	Hyde TM	Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia.	The Journal of neuroscience 	2011	77
23591000	2571	Waters AM	Biased attention to threat in paediatric anxiety disorders (generalized anxiety disorder, social phobia, specific phobia, separation anxiety disorder) as a function of 'distress' versus 'fear' diagnostic categorization.	Psychological medicine	2014	23
24448211	2571	Zhubi A	Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum.	Translational psychiatry	2014	41
17339617	2572	Kroenke K	Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.	Annals of internal medicine	2007	293
17595272	2572	Writing Group for the SEARCH for Diabetes in Youth Study Group.	Incidence of diabetes in youth in the United States.	JAMA	2007	267
19120261	2572	TEDDY Study Group.	The Environmental Determinants of Diabetes in the Young (TEDDY) Study.	Annals of the New York Academy of Sciences	2008	60
20633738	2572	Kroenke K	The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review.	General hospital psychiatry	2010	272
22296077	2572	Ludvigsson J	GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.	The New England journal of medicine	2012	60
22441569	2572	Parikka V	Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk.	Diabetologia	2012	37
23780460	2572	Ziegler AG	Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.	JAMA	2013	102
11138011	2670	Brenner M	Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease.	Nature genetics	2001	112
16320258	2670	Quiñones-Hinojosa A	Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells.	The Journal of comparative neurology	2006	122
18240313	2670	Lee Y	GFAP promoter elements required for region-specific and astrocyte-specific expression.	Glia	2008	62
19279265	2670	Oberheim NA	Uniquely hominid features of adult human astrocytes.	The Journal of neuroscience 	2009	183
19816235	2670	Ballabh P	Intraventricular hemorrhage in premature infants: mechanism of disease.	Pediatric research	2010	77
21079180	2670	Vos PE	GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study.	Neurology	2010	62
21280078	2670	Gunnarsson M	Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.	Annals of neurology	2011	41
22517109	2670	Metting Z	GFAP and S100B in the acute phase of mild traumatic brain injury.	Neurology	2012	38
24332821	2670	Chalak LF	Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy.	The Journal of pediatrics	2014	22
24501367	2670	Sosunov AA	Phenotypic heterogeneity and plasticity of isocortical and hippocampal astrocytes in the human brain.	The Journal of neuroscience 	2014	23
24903744	2670	Papa L	GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.	Journal of neurotrauma	2014	24
25034944	2670	Chen C	Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells.	Nature communications	2014	35
27018834	2670	Papa L	Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury.	JAMA neurology	2016	20
10477776	2688	Takala J	Increased mortality associated with growth hormone treatment in critically ill adults.	The New England journal of medicine	1999	108
12119665	2688	Björntorp P	Do stress reactions cause abdominal obesity and comorbidities?	Obesity reviews 	2001	179
16894525	2688	Gurney JG	Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia.	Cancer	2006	61
18256394	2688	Merideth MA	Phenotype and course of Hutchinson-Gilford progeria syndrome.	The New England journal of medicine	2008	138
18782877	2688	Cohen P	Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.	The Journal of clinical endocrinology and metabolism	2008	67
19409844	2688	Boyd N	Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study.	The Lancet. Oncology	2009	49
19581535	2688	Merchant TE	Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits.	Journal of clinical oncology 	2009	53
20584998	2688	Tong J	Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans.	Diabetes	2010	77
21464293	2688	Chou SH	Leptin is an effective treatment for hypothalamic amenorrhea.	Proceedings of the National Academy of Sciences of the United States of America	2011	44
22043168	2688	Butler MG	Prader-Willi Syndrome: Obesity due to Genomic Imprinting.	Current genomics	2011	39
23303913	2688	Tchernof A	Pathophysiology of human visceral obesity: an update.	Physiological reviews	2013	212
23418415	2688	Munch EM	Transcriptome profiling of microRNA by Next-Gen deep sequencing reveals known and novel miRNA species in the lipid fraction of human breast milk.	PloS one	2013	37
24825400	2688	Chia DJ	Minireview: mechanisms of growth hormone-mediated gene regulation.	Molecular endocrinology	2014	22
15592461	2706	Beltramello M	Impaired permeability to Ins(1,4,5)P3 in a mutant connexin underlies recessive hereditary deafness.	Nature cell biology	2005	79
15752533	2706	Smith RJ	Sensorineural hearing loss in children.	Lancet	2005	93
22678292	2706	Li Y	Clonally related visual cortical neurons show similar stimulus feature selectivity.	Nature	2012	61
11439963	2717	Eng CM	Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.	The New England journal of medicine	2001	178
16773563	2717	Spada M	High incidence of later-onset fabry disease revealed by newborn screening.	American journal of human genetics	2006	120
17409312	2717	Germain DP	Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.	Journal of the American Society of Nephrology 	2007	73
18287059	2717	Aerts JM	Elevated globotriaosylsphingosine is a hallmark of Fabry disease.	Proceedings of the National Academy of Sciences of the United States of America	2008	96
18940466	2717	Zarate YA	Fabry's disease.	Lancet	2008	81
23922385	2717	van der Tol L	A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance.	Journal of medical genetics	2014	24
1944469	2778	Weinstein LS	Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.	The New England journal of medicine	1991	202
12952917	2778	Riminucci M	FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.	The Journal of clinical investigation	2003	128
18489744	2778	Dumitrescu CE	McCune-Albright syndrome.	Orphanet journal of rare diseases	2008	52
25150496	2778	He X	The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma.	Nature medicine	2014	28
25807286	2778	Gudbjartsson DF	Large-scale whole-genome sequencing of the Icelandic population.	Nature genetics	2015	98
9738173	2875	-	Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.	Pediatrics	1998	307
12606734	2875	Hadziyannis SJ	Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.	The New England journal of medicine	2003	131
12897283	2875	van den Hout HM	The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature.	Pediatrics	2003	81
15361502	2875	Chan HL	Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.	Gut	2004	100
15867021	2875	Schwimmer JB	Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.	Pediatrics	2005	81
15871997	2875	Yuen MF	Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.	Gut	2005	74
18094378	2875	Lai CL	Telbivudine versus lamivudine in patients with chronic hepatitis B.	The New England journal of medicine	2007	144
19585618	2875	Feldstein AE	Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.	Hepatology	2009	123
20064512	2875	Schwimmer JB	SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.	Gastroenterology	2010	46
20417857	2875	Tshefu AK	Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.	Lancet	2010	44
20959817	2875	Yin J	Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma.	The American journal of gastroenterology	2011	38
21126940	2875	Cave M	Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004.	Environmental health perspectives	2010	45
21505361	2875	Vajro P	Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease.	Journal of pediatric gastroenterology and nutrition	2011	47
21521847	2875	Lavine JE	Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.	JAMA	2011	155
21688282	2875	Bhala N	The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.	Hepatology	2011	78
21846782	2875	Wong VW	Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.	Gut	2012	62
22362824	2875	van der Lely AJ	Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY.	The Journal of clinical endocrinology and metabolism	2012	31
22546742	2875	Karlsson CL	The microbiota of the gut in preschool children with normal and excessive body weight.	Obesity	2012	64
24107395	2875	Gordon SC	Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.	Clinical gastroenterology and hepatology 	2014	25
24569542	2875	Chiu S	Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials.	European journal of clinical nutrition	2014	28
25140957	2875	DeVincenzo JP	Oral GS-5806 activity in a respiratory syncytial virus challenge study.	The New England journal of medicine	2014	51
26512983	2875	Anderson EL	The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.	PloS one	2015	22
15554887	2908	Seckl JR	Prenatal glucocorticoids and long-term programming.	European journal of endocrinology	2004	104
15677396	2908	Seckl JR	Glucocorticoid programming.	Annals of the New York Academy of Sciences	2004	110
18536531	2908	Oberlander TF	Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses.	Epigenetics	2008	301
19234457	2908	McGowan PO	Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse.	Nature neuroscience	2009	629
19624809	2908	Wong HR	Identification of pediatric septic shock subclasses based on genome-wide expression profiling.	BMC medicine	2009	59
20431047	2908	Miller GE	Harsh family climate in early life presages the emergence of a proinflammatory phenotype in adolescence.	Psychological science	2010	73
21521940	2908	Filiberto AC	Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta.	Epigenetics	2011	47
21705885	2908	Wong HR	Validation of a gene expression-based subclassification strategy for pediatric septic shock.	Critical care medicine	2011	36
21980503	2908	Charmandari E	Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man.	PloS one	2011	38
22295073	2908	Tyrka AR	Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults.	PloS one	2012	106
22444201	2908	Labonte B	Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and methylation in suicide completers with a history of childhood abuse.	Biological psychiatry	2012	70
22714792	2908	Bromer C	Genetic and epigenetic variation of the glucocorticoid receptor (NR3C1) in placenta and infant neurobehavior.	Developmental psychobiology	2013	41
22832523	2908	Radtke KM	Transgenerational impact of intimate partner violence on methylation in the promoter of the glucocorticoid receptor.	Translational psychiatry	2011	90
23566423	2908	Hompes T	Investigating the influence of maternal cortisol and emotional state during pregnancy on the DNA methylation status of the glucocorticoid receptor gene (NR3C1) promoter region in cord blood.	Journal of psychiatric research	2013	42
24135662	2908	Conradt E	The roles of DNA methylation of NR3C1 and 11β-HSD2 and exposure to maternal mood disorder in utero on newborn neurobehavior.	Epigenetics	2013	49
24465557	2908	Na KS	Association between glucocorticoid receptor methylation and hippocampal subfields in major depressive disorder.	PloS one	2014	20
24832930	2908	Yehuda R	Influences of maternal and paternal PTSD on epigenetic regulation of the glucocorticoid receptor gene in Holocaust survivor offspring.	The American journal of psychiatry	2014	36
25336632	2908	Jing D	Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.	Blood	2015	21
25875334	2908	Braithwaite EC	Maternal prenatal depressive symptoms predict infant NR3C1 1F and BDNF IV DNA methylation.	Epigenetics	2015	25
15590760	3075	Dragon-Durey MA	Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome.	Journal of the American Society of Nephrology 	2005	76
15800116	3075	Appel GB	Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.	Journal of the American Society of Nephrology 	2005	72
17018561	3075	Servais A	Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.	Journal of medical genetics	2007	62
17599974	3075	Sellier-Leclerc AL	Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.	Journal of the American Society of Nephrology 	2007	69
18190458	3075	Pickering MC	Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.	Clinical and experimental immunology	2008	50
20595690	3075	Noris M	Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.	Clinical journal of the American Society of Nephrology 	2010	127
21415311	3075	Sethi S	Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.	Clinical journal of the American Society of Nephrology 	2011	36
22223606	3075	Zhang Y	Causes of alternative pathway dysregulation in dense deposit disease.	Clinical journal of the American Society of Nephrology 	2012	32
22456601	3075	Servais A	Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.	Kidney international	2012	69
22673887	3075	Sethi S	C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.	Kidney international	2012	45
23307876	3075	Fremeaux-Bacchi V	Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.	Clinical journal of the American Society of Nephrology 	2013	72
23431077	3075	Bresin E	Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.	Journal of the American Society of Nephrology 	2013	46
24009156	3075	Browall S	Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children.	The Journal of infectious diseases	2014	24
24088957	3075	Sinha A	Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.	Kidney international	2014	21
25204844	3075	Mullins RF	The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning.	The American journal of pathology	2014	22
25402769	3075	Blaum BS	Structural basis for sialic acid-mediated self-recognition by complement factor H.	Nature chemical biology	2015	36
25859752	3075	Loirat C	An international consensus approach to the management of atypical hemolytic uremic syndrome in children.	Pediatric nephrology	2016	24
26061751	3075	Cancer Genome Atlas Research Network.	Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.	The New England journal of medicine	2015	209
15592417	3105	Kiepiela P	Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.	Nature	2004	328
17560447	3105	Eapen M	Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.	Lancet	2007	156
17785583	3105	Lee SJ	High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.	Blood	2007	242
18723429	3105	Kurtzberg J	Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies.	Blood	2008	70
19151783	3105	Willemze R	KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.	Leukemia	2009	53
20089963	3105	Spellman S	The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.	Blood	2010	54
20558104	3105	Eapen M	Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.	The Lancet. Oncology	2010	107
21149285	3105	Ozeki T	Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.	Human molecular genetics	2011	57
23741009	3105	Torikai H	Toward eliminating HLA class I expression to generate universal cells from allogeneic donors.	Blood	2013	37
24046013	3105	Fürst D	High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.	Blood	2013	25
26267621	3105	Petersdorf EW	High HLA-DP Expression and Graft-versus-Host Disease.	The New England journal of medicine	2015	19
11460164	3106	Goulder PJ	Evolution and transmission of stable CTL escape mutations in HIV infection.	Nature	2001	205
16864058	3106	Farag SS	The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.	Biology of blood and marrow transplantation 	2006	79
17892322	3106	Lewinsohn DA	Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.	PLoS pathogens	2007	57
18256392	3106	Mallal S	HLA-B*5701 screening for hypersensitivity to abacavir.	The New England journal of medicine	2008	262
18444831	3106	Saag M	High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.	Clinical infectious diseases 	2008	67
19307327	3106	Crawford H	Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.	The Journal of experimental medicine	2009	100
20205591	3106	Pelak K	Host determinants of HIV-1 control in African Americans.	The Journal of infectious diseases	2010	68
21320923	3106	Daar ES	Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.	Annals of internal medicine	2011	87
22322005	3106	Wei CY	Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.	The Journal of allergy and clinical immunology	2012	37
23993278	3106	Colbert RA	HLA-B27 misfolding and ankylosing spondylitis.	Molecular immunology	2014	23
25140823	3106	Lin P	HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats.	PloS one	2014	28
8072542	3119	Davies JL	A genome-wide search for human type 1 diabetes susceptibility genes.	Nature	1994	174
14519706	3119	Ziegler AG	Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies.	JAMA	2003	95
17244711	3119	Nelson JL	Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism.	Proceedings of the National Academy of Sciences of the United States of America	2007	60
17292770	3119	Dauvilliers Y	Narcolepsy with cataplexy.	Lancet	2007	99
18814906	3119	Näntö-Salonen K	Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.	Lancet	2008	74
19522996	3119	Erkkola M	Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children.	Clinical and experimental allergy 	2009	73
22470463	3119	Partinen M	Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.	PloS one	2012	61
24550192	3119	Kallionpää H	Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility.	Diabetes	2014	27
25710614	3119	Hong X	Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children.	Nature communications	2015	15
26359881	3119	Bashey A	Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index.	Biology of blood and marrow transplantation 	2016	16
19228619	3417	Yan H	IDH1 and IDH2 mutations in gliomas.	The New England journal of medicine	2009	972
19636000	3417	Sanson M	Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.	Journal of clinical oncology 	2009	178
19805672	3417	Weller M	Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.	Journal of clinical oncology 	2009	135
20160062	3417	van den Bent MJ	IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.	Clinical cancer research 	2010	88
20508616	3417	Tefferi A	IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis.	Leukemia	2010	72
20513808	3417	Reitman ZJ	Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.	Journal of the National Cancer Institute	2010	101
20567020	3417	Paschka P	IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication.	Journal of clinical oncology 	2010	152
20625116	3417	Boissel N	Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group.	Journal of clinical oncology 	2010	45
20805365	3417	Schnittger S	IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status.	Blood	2010	41
20975057	3417	Houillier C	IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.	Neurology	2010	84
21088844	3417	Hartmann C	Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.	Acta neuropathologica	2010	98
21289278	3417	Reitman ZJ	Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome.	Proceedings of the National Academy of Sciences of the United States of America	2011	143
21326614	3417	Jin G	2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations.	PloS one	2011	47
22180306	3417	Borger DR	Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.	The oncologist	2012	126
22415316	3417	Gorovets D	IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.	Clinical cancer research 	2012	40
22899282	3417	Duncan CG	A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation.	Genome research	2012	48
23641016	3417	DiNardo CD	Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia.	Blood	2013	35
23793099	3417	Tönjes M	BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.	Nature medicine	2013	63
23954893	3417	Chaturvedi A	Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML.	Blood	2013	43
24722048	3417	Killela PJ	Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas.	Oncotarget	2014	45
24810474	3417	Cai J	ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples.	Oncotarget	2014	22
25701198	3417	Olar A	IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.	Acta neuropathologica	2015	17
27270107	3417	Wang J	Clonal evolution of glioblastoma under therapy.	Nature genetics	2016	15
27806376	3417	Tirosh I	Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma.	Nature	2016	17
15231934	3423	Krous HF	Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach.	Pediatrics	2004	77
16912578	3423	Muenzer J	A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome).	Genetics in medicine 	2006	113
17980736	3423	Moon RY	Sudden infant death syndrome.	Lancet	2007	60
18038146	3423	Wraith JE	Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.	European journal of pediatrics	2008	73
21150784	3423	Muenzer J	Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome.	Genetics in medicine 	2011	37
9176497	3458	Döcke WD	Monocyte deactivation in septic patients: restoration by IFN-gamma treatment.	Nature medicine	1997	203
9923875	3458	Prescott SL	Development of allergen-specific T-cell memory in atopic and normal children.	Lancet	1999	100
10226067	3458	Baldini M	A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E.	American journal of respiratory cell and molecular biology	1999	125
10905243	3458	Gereda JE	Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma.	Lancet	2000	90
11170064	3458	To KF	Pathology of fatal human infection associated with avian influenza A H5N1 virus.	Journal of medical virology	2001	104
11781358	3458	Kukreja A	Multiple immuno-regulatory defects in type-1 diabetes.	The Journal of clinical investigation	2002	156
12001037	3458	Libraty DH	Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.	The Journal of infectious diseases	2002	160
12239255	3458	Braun-Fahrländer C	Environmental exposure to endotoxin and its relation to asthma in school-age children.	The New England journal of medicine	2002	250
12750172	3458	Dufour C	TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro.	Blood	2003	82
12898444	3458	Wang SM	Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema.	The Journal of infectious diseases	2003	75
15383574	3458	Moseman EA	Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.	Journal of immunology	2004	139
15941805	3458	Kang YA	Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country.	JAMA	2005	81
16258194	3458	Arican O	Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.	Mediators of inflammation	2005	91
16360218	3458	Molloy CA	Elevated cytokine levels in children with autism spectrum disorder.	Journal of neuroimmunology	2006	68
16374252	3458	Fuss IJ	Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody.	Inflammatory bowel diseases	2006	68
16547287	3458	Longhi MS	Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.	Journal of immunology	2006	64
16803570	3458	Feuchtinger T	Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.	British journal of haematology	2006	65
16931093	3458	Leyten EM	Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis.	Microbes and infection	2006	87
17255300	3458	Ochoa AC	Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma.	Clinical cancer research 	2007	133
17641064	3458	Admyre C	Exosomes with immune modulatory features are present in human breast milk.	Journal of immunology	2007	168
17948267	3458	Beveridge NE	Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.	European journal of immunology	2007	102
18037347	3458	Martire B	Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study.	Clinical immunology	2008	52
18292584	3458	Soares AP	Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.	Journal of immunology	2008	81
18448618	3458	Forrest BD	Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.	Clinical and vaccine immunology 	2008	62
18554755	3458	Elias D	Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production.	Vaccine	2008	59
18582195	3458	Hawkridge T	Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.	The Journal of infectious diseases	2008	63
18624725	3458	Wang M	The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro.	Immunology	2009	57
19105884	3458	Pai M	T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India.	The international journal of tuberculosis and lung disease 	2009	45
19336372	3458	Ambalavanan N	Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants.	Pediatrics	2009	69
19342414	3458	van Zyl-Smit RN	Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.	American journal of respiratory and critical care medicine	2009	50
19577283	3458	Jones SM	Clinical efficacy and immune regulation with peanut oral immunotherapy.	The Journal of allergy and clinical immunology	2009	135
19608159	3458	Yoo KH	Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.	Cellular immunology	2009	80
19636353	3458	Malhotra I	Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya.	PLoS medicine	2009	62
19740775	3458	Rovedatti L	Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease.	Gut	2009	67
19822900	3458	Gutman JA	Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.	Blood	2010	44
19875682	3458	Mauad T	Lung pathology in fatal novel human influenza A (H1N1) infection.	American journal of respiratory and critical care medicine	2010	99
20063313	3458	Wammes LJ	Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum.	European journal of immunology	2010	46
20146084	3458	Ardon H	Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.	Journal of neuro-oncology	2010	41
20194818	3458	Wright RJ	Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort.	American journal of respiratory and critical care medicine	2010	58
20226890	3458	van Dissel JT	Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers.	Vaccine	2010	61
20368575	3458	Vermijlen D	Human cytomegalovirus elicits fetal gammadelta T cell responses in utero.	The Journal of experimental medicine	2010	50
20558627	3458	Kagina BM	Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns.	American journal of respiratory and critical care medicine	2010	108
21281959	3458	Kim EH	Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization.	The Journal of allergy and clinical immunology	2011	63
21288814	3458	Skowronski DM	Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.	The Journal of infectious diseases	2011	41
21368230	3458	McClymont SA	Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.	Journal of immunology	2011	98
21624938	3458	Zoller EE	Hemophagocytosis causes a consumptive anemia of inflammation.	The Journal of experimental medicine	2011	37
21669030	3458	Mandalakas AM	Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis.	The international journal of tuberculosis and lung disease 	2011	42
21775682	3458	Day CL	Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load.	Journal of immunology	2011	84
21810230	3458	Goines PE	Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study.	Molecular autism	2011	61
22539471	3458	Singh OP	Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.	Clinical and vaccine immunology 	2012	33
23169501	3458	Icheva V	Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation.	Journal of clinical oncology 	2013	47
23260195	3458	Sathaliyawala T	Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets.	Immunity	2013	127
23331510	3458	Salahuddin N	Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study Supplementary Cholecalciferol in recovery from tuberculosis. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'.	BMC infectious diseases	2013	36
23414212	3458	Sellarés J	Molecular diagnosis of antibody-mediated rejection in human kidney transplants.	American journal of transplantation 	2013	30
23999600	3458	Garg A	HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.	The Journal of infectious diseases	2014	22
24434782	3458	Leong JW	Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.	Biology of blood and marrow transplantation 	2014	40
24442432	3458	Della Chiesa M	Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.	Journal of immunology	2014	31
24518246	3458	Voraphani N	An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthma.	Mucosal immunology	2014	20
25210141	3458	Jensen KJ	Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial.	The Journal of infectious diseases	2015	19
25562578	3458	Andrews JR	The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents.	American journal of respiratory and critical care medicine	2015	17
25611466	3458	Gideon HP	Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization.	PLoS pathogens	2015	42
25647269	3458	Talaat RM	Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.	Cytokine	2015	23
25703555	3458	Boisson-Dupuis S	Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.	Immunological reviews	2015	21
26405286	3458	Getahun H	Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.	The European respiratory journal	2015	21
27068708	3458	Fletcher HA	T-cell activation is an immune correlate of risk in BCG vaccinated infants.	Nature communications	2016	16
8156941	3479	Thissen JP	Nutritional regulation of the insulin-like growth factors.	Endocrine reviews	1994	133
11679420	3479	Goran MI	Longitudinal study on pubertal insulin resistance.	Diabetes	2001	112
12843179	3479	Bonafè M	Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control.	The Journal of clinical endocrinology and metabolism	2003	84
14671005	3479	van der Eerden BC	Systemic and local regulation of the growth plate.	Endocrine reviews	2003	77
16331359	3479	Cooper C	Review: developmental origins of osteoporotic fracture.	Osteoporosis international 	2006	62
16537681	3479	Ibáñez L	Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children.	The Journal of clinical endocrinology and metabolism	2006	72
17332988	3479	Chen J	Retinopathy of prematurity.	Angiogenesis	2007	123
18003755	3479	Hyppönen E	25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort.	Diabetes	2008	88
19789339	3479	Kurmasheva RT	The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma.	Cancer research	2009	56
20371689	3479	Kurzrock R	A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors.	Clinical cancer research 	2010	67
20621847	3479	Boas M	Childhood exposure to phthalates: associations with thyroid function, insulin-like growth factor I, and growth.	Environmental health perspectives	2010	48
21195217	3479	Bredella MA	Determinants of bone mineral density in obese premenopausal women.	Bone	2011	40
22025154	3479	Juergens H	Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma.	Journal of clinical oncology 	2011	57
22184397	3479	Malempati S	Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.	Journal of clinical oncology 	2012	56
22923132	3479	Gentilini D	Role of epigenetics in human aging and longevity: genome-wide DNA methylation profile in centenarians and centenarians' offspring.	Age	2013	43
23483175	3479	Martin RM	Effects of promoting longer-term and exclusive breastfeeding on adiposity and insulin-like growth factor-I at age 11.5 years: a randomized trial.	JAMA	2013	33
23782686	3479	Hellström A	Retinopathy of prematurity.	Lancet	2013	62
23956055	3479	Weigel B	Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group.	Pediatric blood and cancer	2014	26
24623853	3479	Khwaja OS	Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2014	38
25208878	3479	Jones RL	Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors.	Clinical cancer research 	2015	21
26154720	3479	Begemann M	Paternally Inherited IGF2 Mutation and Growth Restriction.	The New England journal of medicine	2015	20
26437621	3479	Baron J	Short and tall stature: a new paradigm emerges.	Nature reviews. Endocrinology	2015	16
8520783	3553	Bonfield TL	Inflammatory cytokines in cystic fibrosis lungs.	American journal of respiratory and critical care medicine	1995	150
9240577	3553	Yoon BH	Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy.	American journal of obstetrics and gynecology	1997	116
9466984	3553	Fadok VA	Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.	The Journal of clinical investigation	1998	656
10617994	3553	James MJ	Dietary polyunsaturated fatty acids and inflammatory mediator production.	The American journal of clinical nutrition	2000	126
15855327	3553	Brusko TM	Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.	Diabetes	2005	83
18438844	3553	Nakasa T	Expression of microRNA-146 in rheumatoid arthritis synovial tissue.	Arthritis and rheumatism	2008	139
19710611	3553	Prasad AS	Zinc: role in immunity, oxidative stress and chronic inflammation.	Current opinion in clinical nutrition and metabolic care	2009	56
19842207	3553	Zhang JY	Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.	Hepatology	2010	89
20398920	3553	Hastie AT	Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes.	The Journal of allergy and clinical immunology	2010	88
20533546	3553	So A	Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study.	Arthritis and rheumatism	2010	52
20705131	3553	Ashwood P	Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.	Brain, behavior, and immunity	2011	120
20940111	3553	Ahmed S	Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood.	Environmental health perspectives	2011	52
21533209	3553	Burl S	Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants.	PloS one	2011	44
21599903	3553	Brochu ME	Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: An experimental study.	Journal of neuroinflammation	2011	36
21872339	3553	Liu Y	Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.	Journal of affective disorders	2012	88
21906753	3553	Pandey GN	Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims.	Journal of psychiatric research	2012	46
22521247	3553	Philbin VJ	Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways.	The Journal of allergy and clinical immunology	2012	32
22925832	3553	Rethorst CD	Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.	Molecular psychiatry	2013	29
23139215	3553	Ganguli K	Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation.	American journal of physiology. Gastrointestinal and liver physiology	2013	40
23306544	3553	Tiringer K	A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection.	American journal of respiratory and critical care medicine	2013	26
23360282	3553	Gola H	Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells.	BMC psychiatry	2013	33
23483986	3553	Dowling DJ	The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.	PloS one	2013	25
24203055	3553	Uhlig HH	Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.	Gut	2013	39
24277153	3553	Guiducci C	RNA recognition by human TLR8 can lead to autoimmune inflammation.	The Journal of experimental medicine	2013	25
24356959	3553	van der Burgh R	Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hypersecretion.	The Journal of biological chemistry	2014	24
24743880	3553	Portugal S	Exposure-dependent control of malaria-induced inflammation in children.	PLoS pathogens	2014	30
25541493	3553	Black C	Meta-Analysis of Cytokines and Chemokines in Suicidality: Distinguishing Suicidal Versus Nonsuicidal Patients.	Biological psychiatry	2015	23
26392128	3553	Krakowiak P	Neonatal Cytokine Profiles Associated With Autism Spectrum Disorder.	Biological psychiatry	2017	9
27270401	3553	Park YH	Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS.	Nature immunology	2016	15
27383986	3553	Liu X	Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores.	Nature	2016	45
3493432	3558	Rosenberg SA	A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.	The New England journal of medicine	1987	221
8028037	3558	Rosenberg SA	Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.	Journal of the National Cancer Institute	1994	157
8120958	3558	Rosenberg SA	Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.	JAMA	1994	150
11675346	3558	Ng WF	Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.	Blood	2001	100
12000866	3558	Dudley ME	A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.	Journal of immunotherapy	2002	86
14974943	3558	Opelz G	Lymphomas after solid organ transplantation: a collaborative transplant study report.	American journal of transplantation 	2004	79
15632206	3558	Miller JS	Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.	Blood	2005	340
15800326	3558	Dudley ME	Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.	Journal of clinical oncology 	2005	443
16121185	3558	Watanabe N	Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus.	Nature	2005	162
17289812	3558	Biancotto A	Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.	Blood	2007	87
18000167	3558	Lange BJ	Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.	Blood	2008	73
18457330	3558	Klapper JA	High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006.	Cancer	2008	60
18809613	3558	Dudley ME	Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.	Journal of clinical oncology 	2008	389
19726501	3558	Migueles SA	Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy.	Journal of virology	2009	67
20085940	3558	Rubnitz JE	NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.	Journal of clinical oncology 	2010	118
20542324	3558	Blumchen K	Oral peanut immunotherapy in children with peanut anaphylaxis.	The Journal of allergy and clinical immunology	2010	70
20881001	3558	Amato RJ	Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study.	Clinical cancer research 	2010	44
20921469	3558	Shusterman S	Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study.	Journal of clinical oncology 	2010	61
20935224	3558	Delgado DC	Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.	Cancer research	2010	50
21498393	3558	Rosenberg SA	Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.	Clinical cancer research 	2011	412
21998698	3558	Olotu A	Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.	PloS one	2011	38
22436957	3558	Tan J	Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.	JAMA	2012	99
22710188	3558	Kennedy PTF	Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B.	Gastroenterology	2012	39
23562009	3558	Gold R	Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.	Lancet	2013	55
23650429	3558	Dudley ME	Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.	Journal of clinical oncology 	2013	44
23741305	3558	Singh H	Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells.	PloS one	2013	39
24094496	3558	Tonn T	Treatment of patients with advanced cancer with the natural killer cell line NK-92.	Cytotherapy	2013	40
24573552	3558	Kennedy-Nasser AA	Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.	Clinical cancer research 	2014	32
24719405	3558	Bachanova V	Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.	Blood	2014	59
24782509	3558	Xu Y	Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15.	Blood	2014	59
25415285	3558	Szmania S	Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients.	Journal of immunotherapy	2015	24
25939024	3558	Thiault N	Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors.	Nature immunology	2015	23
25940712	3558	Ninomiya S	Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs.	Blood	2015	25
27073224	3558	Koreth J	Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease.	Blood	2016	15
27500725	3558	He J	Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.	Nature medicine	2016	11
9704787	3569	Gomez R	The fetal inflammatory response syndrome.	American journal of obstetrics and gynecology	1998	161
9769329	3569	Fishman D	The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.	The Journal of clinical investigation	1998	297
11388092	3569	Pinede L	Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases.	Medicine	2001	92
11445664	3569	Vozarova B	Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion.	Obesity research	2001	86
12393667	3569	Silliman CC	Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors.	Blood	2003	94
14567964	3569	Raper SE	Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.	Molecular genetics and metabolism	2003	272
15886319	3569	Kemna E	Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS.	Blood	2005	105
16012934	3569	Hart AL	Characteristics of intestinal dendritic cells in inflammatory bowel diseases.	Gastroenterology	2005	95
16849509	3569	Levy O	The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn.	Journal of immunology	2006	71
16864705	3569	Angelone DF	Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo.	Pediatric research	2006	61
16870554	3569	Lu LL	Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.	Haematologica	2006	121
16946190	3569	Pace TW	Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress.	The American journal of psychiatry	2006	172
16949415	3569	Andrews WW	The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants.	American journal of obstetrics and gynecology	2006	64
17170049	3569	de Jager W	Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.	Annals of the rheumatic diseases	2007	62
17446340	3569	Törnqvist H	Persistent endothelial dysfunction in humans after diesel exhaust inhalation.	American journal of respiratory and critical care medicine	2007	94
17716366	3569	Jeschke MG	Burn size determines the inflammatory and hypermetabolic response.	Critical care	2007	58
17825619	3569	Gozal D	Systemic inflammation in non-obese children with obstructive sleep apnea.	Sleep medicine	2008	51
18242584	3569	Brydon L	Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans.	Biological psychiatry	2008	81
18540734	3569	Zautra AJ	Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression.	Journal of consulting and clinical psychology	2008	69
18771602	3569	Kauer-Sant'Anna M	Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.	The international journal of neuropsychopharmacology	2009	49
18776137	3569	Miao F	Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.	Diabetes	2008	53
18791359	3569	Jeschke MG	Pathophysiologic response to severe burn injury.	Annals of surgery	2008	137
18971361	3569	Han YW	Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth.	Journal of clinical microbiology	2009	79
19073750	3569	Miller GE	Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later.	Psychosomatic medicine	2009	53
19118018	3569	Ara T	Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.	Cancer research	2009	51
19376240	3569	Eisenberger NI	An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences.	NeuroImage	2009	61
19440509	3569	Liu L	Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children.	Environmental health perspectives	2009	57
19460915	3569	Catalano PM	Fetuses of obese mothers develop insulin resistance in utero.	Diabetes care	2009	132
19500472	3569	Chang YS	Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.	Cell transplantation	2009	50
20043983	3569	Eisenberger NI	Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood.	Brain, behavior, and immunity	2010	78
20086201	3569	Christiansen T	Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study.	American journal of physiology. Endocrinology and metabolism	2010	47
20180702	3569	Gordon MA	Invasive non-typhoid salmonellae establish systemic intracellular infection in HIV-infected adults: an emerging disease pathogenesis.	Clinical infectious diseases 	2010	43
20215512	3569	Lin L	Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.	Cancer research	2010	67
20335016	3569	Ara T	Interleukin-6 in bone metastasis and cancer progression.	European journal of cancer	2010	80
20622030	3569	DeVincenzo JP	Viral load drives disease in humans experimentally infected with respiratory syncytial virus.	American journal of respiratory and critical care medicine	2010	72
20679216	3569	Slavich GM	Neural sensitivity to social rejection is associated with inflammatory responses to social stress.	Proceedings of the National Academy of Sciences of the United States of America	2010	78
21346738	3569	Conti HR	New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome.	Mucosal immunology	2011	41
21519361	3569	Begue B	Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease.	The American journal of gastroenterology	2011	40
21801830	3569	Pace TW	Increased peripheral NF-κB pathway activity in women with childhood abuse-related posttraumatic stress disorder.	Brain, behavior, and immunity	2012	42
21946257	3569	Baryawno N	Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.	The Journal of clinical investigation	2011	59
22146091	3569	Pervanidou P	Metabolic consequences of stress during childhood and adolescence.	Metabolism	2012	45
22411804	3569	Villenave R	In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2012	46
22426431	3569	Coussons-Read ME	The occurrence of preterm delivery is linked to pregnancy-specific distress and elevated inflammatory markers across gestation.	Brain, behavior, and immunity	2012	40
23252525	3569	De Benedetti F	Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.	The New England journal of medicine	2012	66
23407306	3569	Belenchia AM	Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial.	The American journal of clinical nutrition	2013	46
23782920	3569	Bellavia A	DNA hypomethylation, ambient particulate matter, and increased blood pressure: findings from controlled human exposure experiments.	Journal of the American Heart Association	2013	37
24417618	3569	Romero R	A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes.	American journal of reproductive immunology	2014	31
24508444	3569	Chang YS	Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial.	The Journal of pediatrics	2014	35
24622416	3569	Gitelman SE	Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.	The lancet. Diabetes and endocrinology	2013	29
24667956	3569	Maude SL	Managing cytokine release syndrome associated with novel T cell-engaging therapies.	Cancer journal	2014	62
24876563	3569	Lee DW	Current concepts in the diagnosis and management of cytokine release syndrome.	Blood	2014	124
25190175	3569	Romero R	Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes.	The journal of maternal-fetal and neonatal medicine 	2015	30
25317870	3569	Maude SL	Chimeric antigen receptor T cells for sustained remissions in leukemia.	The New England journal of medicine	2014	447
25456364	3569	Kennedy GA	Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.	The Lancet. Oncology	2014	26
25505246	3569	Park H	MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins.	The Journal of biological chemistry	2015	26
25598426	3569	Moieni M	Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression.	Neuropsychopharmacology 	2015	36
25720095	3569	Romero R	Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques.	Journal of perinatal medicine	2015	22
25802036	3569	de Vrij J	Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.	International journal of cancer	2015	18
25849830	3569	Couturier J	Human adipose tissue as a reservoir for memory CD4+ T cells and HIV.	AIDS	2015	16
26169573	3569	Strawbridge R	Inflammation and clinical response to treatment in depression: A meta-analysis.	European neuropsychopharmacology 	2015	24
26428501	3569	Kim CJ	Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance.	American journal of obstetrics and gynecology	2015	26
27070405	3569	Coughlin JM	In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using (11)CDPA-713 PET and analysis of CSF and plasma.	Translational psychiatry	2016	14
27076371	3569	Teachey DT	Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.	Cancer discovery	2016	23
1357346	3630	Martin BC	Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.	Lancet	1992	138
1954451	3630	Hales CN	Fetal and infant growth and impaired glucose tolerance at age 64.	BMJ	1991	360
7613432	3630	Barker DJ	Fetal origins of coronary heart disease.	BMJ	1995	394
7677463	3630	Pories WJ	Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.	Annals of surgery	1995	248
8436255	3630	Barker DJ	Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth.	Diabetologia	1993	325
8447318	3630	Spielman RS	Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).	American journal of human genetics	1993	715
8627431	3630	Pinhas-Hamiel O	Increased incidence of non-insulin-dependent diabetes mellitus among adolescents.	The Journal of pediatrics	1996	115
9042129	3630	Anderson B	Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus.	The Journal of pediatrics	1997	108
9303923	3630	Ferrannini E	Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).	The Journal of clinical investigation	1997	116
10512371	3630	Moran A	Insulin resistance during puberty: results from clamp studies in 357 children.	Diabetes	1999	131
11274526	3630	Visscher TL	The public health impact of obesity.	Annual review of public health	2001	128
11533341	3630	Freedman DS	Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study.	Pediatrics	2001	213
11809615	3630	Hales CN	The thrifty phenotype hypothesis.	British medical bulletin	2001	378
11893791	3630	Sinha R	Prevalence of impaired glucose tolerance among children and adolescents with marked obesity.	The New England journal of medicine	2002	208
12037147	3630	Diabetes Prevention Trial--Type 1 Diabetes Study Group.	Effects of insulin in relatives of patients with type 1 diabetes mellitus.	The New England journal of medicine	2002	136
12364344	3630	Sorof J	Obesity hypertension in children: a problem of epidemic proportions.	Hypertension	2002	97
12367816	3630	Barker DJ	Fetal programming of coronary heart disease.	Trends in endocrinology and metabolism	2002	122
12642369	3630	Steinberger J	Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism).	Circulation	2003	121
12679416	3630	Goran MI	Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents.	The Journal of clinical endocrinology and metabolism	2003	100
12750520	3630	Petersen KF	Mitochondrial dysfunction in the elderly: possible role in insulin resistance.	Science	2003	450
14704320	3630	Yajnik CS	Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries.	The Journal of nutrition	2004	81
14715836	3630	Cruz ML	The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.	The Journal of clinical endocrinology and metabolism	2004	100
14985484	3630	Bhargava SK	Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood.	The New England journal of medicine	2004	186
15288712	3630	Benedict C	Intranasal insulin improves memory in humans.	Psychoneuroendocrinology	2004	106
15548778	3630	Hofman PL	Premature birth and later insulin resistance.	The New England journal of medicine	2004	76
15564314	3630	Gershengorn MC	Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells.	Science	2004	100
15639678	3630	Pereira MA	Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis.	Lancet	2005	228
15910627	3630	Donnelly LA	Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.	Diabetic medicine 	2005	74
15951574	3630	Crowther CA	Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.	The New England journal of medicine	2005	333
16061606	3630	Hannon TS	Childhood obesity and type 2 diabetes mellitus.	Pediatrics	2005	67
16249280	3630	Coviello AD	Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.	The Journal of clinical endocrinology and metabolism	2006	74
16704347	3630	King JC	Maternal obesity, metabolism, and pregnancy outcomes.	Annual review of nutrition	2006	62
16740839	3630	Clark RH	Reported medication use in the neonatal intensive care unit: data from a large national data set.	Pediatrics	2006	71
16860699	3630	Andersen LB	Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study).	Lancet	2006	225
17021763	3630	Sommer DM	Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.	Archives of dermatological research	2006	84
17065679	3630	Lee JM	Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study.	Diabetes care	2006	99
17194189	3630	Ekelund U	TV viewing and physical activity are independently associated with metabolic risk in children: the European Youth Heart Study.	PLoS medicine	2006	123
17507704	3630	Hovi P	Glucose regulation in young adults with very low birth weight.	The New England journal of medicine	2007	78
18070991	3630	Sardinha LB	Objectively measured time spent sedentary is associated with insulin resistance independent of overall and central body fat in 9- to 10-year-old Portuguese children.	Diabetes care	2008	58
18162506	3630	Edghill EL	Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.	Diabetes	2008	80
18192540	3630	Molven A	Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes.	Diabetes	2008	50
18197184	3630	Trapp EG	The effects of high-intensity intermittent exercise training on fat loss and fasting insulin levels of young women.	International journal of obesity	2008	57
18285809	3630	Farrant HJ	Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size.	European journal of clinical nutrition	2009	48
18312311	3630	James WP	The epidemiology of obesity: the size of the problem.	Journal of internal medicine	2008	137
18451997	3630	Colombo C	Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus.	The Journal of clinical investigation	2008	60
18463376	3630	Rowan JA	Metformin versus insulin for the treatment of gestational diabetes.	The New England journal of medicine	2008	103
18769702	3630	Vos MB	Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey.	Medscape journal of medicine	2008	90
18802479	3630	Skowera A	CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.	The Journal of clinical investigation	2008	115
19208729	3630	Teff KL	Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses.	The Journal of clinical endocrinology and metabolism	2009	78
19528367	3630	Wilding JP	A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment.	Diabetes care	2009	80
19588120	3630	Jonasson JM	Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden.	Diabetologia	2009	97
19759171	3630	Catalano PM	Perinatal risk factors for childhood obesity and metabolic dysregulation.	The American journal of clinical nutrition	2009	100
19797280	3630	Landon MB	A multicenter, randomized trial of treatment for mild gestational diabetes.	The New England journal of medicine	2009	227
19915016	3630	Nadeau KJ	Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.	The Journal of clinical endocrinology and metabolism	2010	71
19966268	3630	Nelson SM	Maternal metabolism and obesity: modifiable determinants of pregnancy outcome.	Human reproduction update	2010	61
20091571	3630	Misso ML	Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.	The Cochrane database of systematic reviews	2010	45
20123614	3630	Nelson JW	Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population.	Environmental health perspectives	2010	44
20581420	3630	HEALTHY Study Group.	A school-based intervention for diabetes risk reduction.	The New England journal of medicine	2010	86
20669500	3630	Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines			2009	702
20802107	3630	Burt Solorzano CM	Obesity and the pubertal transition in girls and boys.	Reproduction	2010	52
20829185	3630	Levy-Marchal C	Insulin resistance in children: consensus, perspective, and future directions.	The Journal of clinical endocrinology and metabolism	2010	50
21109577	3630	Lawlor DA	Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study.	BMJ	2010	73
21321035	3630	Seifert SM	Health effects of energy drinks on children, adolescents, and young adults.	Pediatrics	2011	100
21562325	3630	Steck AK	Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.	Diabetes care	2011	56
21730284	3630	Giannini C	The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds.	Diabetes care	2011	41
21947005	3630	Arner P	Dynamics of human adipose lipid turnover in health and metabolic disease.	Nature	2011	53
22124462	3630	Yu L	Distinguishing persistent insulin autoantibodies with differential risk: nonradioactive bivalent proinsulin/insulin autoantibody assay.	Diabetes	2012	32
22167125	3630	Dai C	Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets.	Diabetologia	2012	53
22344039	3630	Fraser A	Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children.	Circulation	2012	52
22431673	3630	Wilding JP	Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.	Annals of internal medicine	2012	81
22745242	3630	Gregg BE	Formation of a human β-cell population within pancreatic islets is set early in life.	The Journal of clinical endocrinology and metabolism	2012	76
23007319	3630	Lawlor DA	Maternal adiposity--a determinant of perinatal and offspring outcomes?	Nature reviews. Endocrinology	2012	42
23015032	3630	Friedemann C	Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis.	BMJ	2012	58
23086558	3630	Herold KC	Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.	Diabetologia	2013	28
23164767	3630	Jacobi J	Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients.	Critical care medicine	2012	64
23166346	3630	Ho M	Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis.	Pediatrics	2012	62
23356701	3630	Weiss R	What is metabolic syndrome, and why are children getting it?	Annals of the New York Academy of Sciences	2013	42
23524641	3630	Butler AE	Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors.	Diabetes	2013	90
23594269	3630	Baudrand R	High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome.	Clinical endocrinology	2014	22
23778747	3630	Ho M	Impact of dietary and exercise interventions on weight change and metabolic outcomes in obese children and adolescents: a systematic review and meta-analysis of randomized trials.	JAMA pediatrics	2013	37
24256086	3630	Nobili V	Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.	American journal of respiratory and critical care medicine	2014	20
24316517	3630	Vrieze A	Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.	Journal of hepatology	2014	48
24519298	3630	Wang G	Preterm birth and random plasma insulin levels at birth and in early childhood.	JAMA	2014	23
24651807	3630	Cobelli C	The oral minimal model method.	Diabetes	2014	24
25642774	3630	Herold KC	β cell death and dysfunction during type 1 diabetes development in at-risk individuals.	The Journal of clinical investigation	2015	30
25825943	3630	Schwarz JM	Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.	The Journal of clinical endocrinology and metabolism	2015	20
26166230	3630	Nusslock R	Early-Life Adversity and Physical and Emotional Health Across the Lifespan: A Neuroimmune Network Hypothesis.	Biological psychiatry	2016	22
19279331	3645	Bradford PT	Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.	Blood	2009	52
20557928	3645	Jewkes RK	Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study.	Lancet	2010	245
23760347	3645	Benros ME	Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study.	JAMA psychiatry	2013	32
24753238	3645	Paterno MV	Incidence of Second ACL Injuries 2 Years After Primary ACL Reconstruction and Return to Sport.	The American journal of sports medicine	2014	37
25801458	3645	Waight PA	Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.	The Lancet. Infectious diseases	2015	49
15115830	3767	Gloyn AL	Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.	The New England journal of medicine	2004	230
16123337	3767	Hattersley AT	Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.	Diabetes	2005	84
16885550	3767	Pearson ER	Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.	The New England journal of medicine	2006	189
17446535	3767	Flanagan SE	Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.	Diabetes	2007	70
21049026	3767	Bonnefond A	Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome.	PloS one	2010	42
7479840	3815	Nagata H	Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.	Proceedings of the National Academy of Sciences of the United States of America	1995	129
12181401	3815	Demetri GD	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.	The New England journal of medicine	2002	651
15365079	3815	Corless CL	Biology of gastrointestinal stromal tumors.	Journal of clinical oncology 	2004	170
17193820	3815	Miettinen M	Gastrointestinal stromal tumors: pathology and prognosis at different sites.	Seminars in diagnostic pathology	2006	236
18076015	3815	Dematteo RP	Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).	Cancer	2008	96
18223323	3815	Espinosa I	A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.	The American journal of surgical pathology	2008	84
19303137	3815	Dematteo RP	Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.	Lancet	2009	245
19522824	3815	Stratakis CA	The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications.	Journal of internal medicine	2009	55
19865100	3815	Bodemer C	Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.	The Journal of investigative dermatology	2010	45
19997612	3815	Presanis AM	The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis.	PLoS medicine	2009	111
21399664	3815	Gao XN	MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.	Oncogene	2011	41
23371930	3815	Xiong Q	Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.	Circulation	2013	30
24170267	3815	Sanada F	c-Kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy.	Circulation research	2014	29
24638003	3815	Corless CL	Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.	Journal of clinical oncology 	2014	30
25605837	3815	Joensuu H	KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence.	Journal of clinical oncology 	2015	17
27011036	3815	Boikos SA	Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.	JAMA oncology	2016	15
9202122	3952	Montague CT	Congenital leptin deficiency is associated with severe early-onset obesity in humans.	Nature	1997	361
10486419	3952	Farooqi IS	Effects of recombinant leptin therapy in a child with congenital leptin deficiency.	The New England journal of medicine	1999	233
11856796	3952	Oral EA	Leptin-replacement therapy for lipodystrophy.	The New England journal of medicine	2002	197
12393845	3952	Farooqi IS	Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.	The Journal of clinical investigation	2002	281
15940121	3952	Cunningham-Rundles S	Mechanisms of nutrient modulation of the immune response.	The Journal of allergy and clinical immunology	2005	76
17690262	3952	Farooqi IS	Leptin regulates striatal regions and human eating behavior.	Science	2007	137
19171638	3952	Mantzoros CS	Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years of age: a prospective cohort study.	Pediatrics	2009	52
19955752	3952	Leproult R	Role of sleep and sleep loss in hormonal release and metabolism.	Endocrine development	2010	66
20138072	3952	Omisade A	Impact of acute sleep restriction on cortisol and leptin levels in young women.	Physiology and behavior	2010	56
25063755	3952	Rosenbaum M	20 years of leptin: role of leptin in energy homeostasis in humans.	The Journal of endocrinology	2014	24
25800063	3952	Allard C	Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns.	Epigenetics	2015	15
10508514	4204	Amir RE	Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.	Nature genetics	1999	1041
15121991	4204	Muhle R	The genetics of autism.	Pediatrics	2004	205
16225830	4204	Armstrong DD	Neuropathology of Rett syndrome.	Journal of child neurology	2005	76
17172942	4204	del Gaudio D	Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males.	Genetics in medicine 	2006	87
18337588	4204	Neul JL	Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome.	Neurology	2008	99
19442733	4204	Chapleau CA	Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.	Neurobiology of disease	2009	71
20035514	4204	Ramocki MB	Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome.	Annals of neurology	2009	74
20425814	4204	Ramocki MB	The MECP2 duplication syndrome.	American journal of medical genetics. Part A	2010	58
21085180	4204	Muotri AR	L1 retrotransposition in neurons is modulated by MeCP2.	Nature	2010	178
21807996	4204	Kim KY	Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2011	71
22037496	4204	Szulwach KE	5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging.	Nature neuroscience	2011	225
24399845	4204	Cuddapah VA	Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome.	Journal of medical genetics	2014	39
26733678	4204	Tang X	KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2016	10
17658395	4297	Pieters R	A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.	Lancet	2007	82
19262598	4297	Meyer C	New insights to the MLL recombinome of acute leukemias.	Leukemia	2009	93
19528532	4297	Balgobind BV	Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.	Blood	2009	58
19535349	4297	Slany RK	The molecular biology of mixed lineage leukemia.	Haematologica	2009	78
20016527	4297	Salzer WL	Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group.	Leukemia	2010	46
20223594	4297	Eden T	Aetiology of childhood leukaemia.	Cancer treatment reviews	2010	47
21118195	4297	Marschalek R	Mechanisms of leukemogenesis by MLL fusion proteins.	British journal of haematology	2011	37
23628958	4297	Meyer C	The MLL recombinome of acute leukemias in 2013.	Leukemia	2013	81
25730765	4297	Andersson AK	The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.	Nature genetics	2015	46
26304874	4297	Pui CH	Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.	Journal of clinical oncology 	2015	33
9545395	4524	van der Put NM	A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?	American journal of human genetics	1998	194
10791559	4524	Botto LD	5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review.	American journal of epidemiology	2000	140
19808787	4524	Greene ND	Genetics of human neural tube defects.	Human molecular genetics	2009	70
20385928	4524	Kenet G	Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies.	Circulation	2010	41
20808944	4524	Devlin AM	Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth.	PloS one	2010	61
22542447	4524	Frustaci A	Oxidative stress-related biomarkers in autism: systematic review and meta-analyses.	Free radical biology and medicine	2012	55
22648721	4524	Schmidt RJ	Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study.	The American journal of clinical nutrition	2012	61
4047115	4613	Seeger RC	Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.	The New England journal of medicine	1985	281
6719137	4613	Brodeur GM	Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.	Science	1984	340
16306521	4613	Attiyeh EF	Chromosome 1p and 11q deletions and outcome in neuroblastoma.	The New England journal of medicine	2005	112
16954472	4613	Asgharzadeh S	Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification.	Journal of the National Cancer Institute	2006	81
17283129	4613	Chen Y	Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.	Cancer research	2007	119
18463370	4613	Maris JM	Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.	The New England journal of medicine	2008	82
19047291	4613	Cohn SL	The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.	Journal of clinical oncology 	2009	226
19171713	4613	Janoueix-Lerosey I	Overall genomic pattern is a predictor of outcome in neuroblastoma.	Journal of clinical oncology 	2009	64
19515614	4613	Vermeulen J	Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.	The Lancet. Oncology	2009	49
20227189	4613	Modak S	Neuroblastoma: Therapeutic strategies for a clinical enigma.	Cancer treatment reviews	2010	42
21768459	4613	London WB	Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project.	Journal of clinical oncology 	2011	38
23430699	4613	Puissant A	Targeting MYCN in neuroblastoma by BET bromodomain inhibition.	Cancer discovery	2013	135
23498719	4613	Rushlow DE	Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.	The Lancet. Oncology	2013	43
23890779	4613	Kreissman SG	Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.	The Lancet. Oncology	2013	36
24009722	4613	Wyce A	BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.	PloS one	2013	32
25533335	4613	Hill RM	Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.	Cancer cell	2015	18
26539795	4613	Bosse KR	Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.	Cancer	2016	14
27040285	4613	Ramaswamy V	Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.	Acta neuropathologica	2016	17
17851649	4709	Yajnik CS	Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study.	Diabetologia	2008	91
22277967	4709	Calvo SE	Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing.	Science translational medicine	2012	103
22742616	4709	Ramakrishnan U	Effect of women's nutrition before and during early pregnancy on maternal and infant outcomes: a systematic review.	Paediatric and perinatal epidemiology	2012	42
24219896	4709	Rush EC	Vitamin B12: one carbon metabolism, fetal growth and programming for chronic disease.	European journal of clinical nutrition	2014	21
24398331	4709	Price S	Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.	Blood	2014	23
9302301	4758	Hayden FG	Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.	The New England journal of medicine	1997	107
9482438	4758	Claas EC	Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.	Lancet	1998	341
10517426	4758	Hayden FG	Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.	JAMA	1999	110
10520648	4758	Cox NJ	Influenza.	Lancet	1999	131
10920197	4758	Lin YP	Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.	Proceedings of the National Academy of Sciences of the United States of America	2000	164
15337401	4758	Kiso M	Resistant influenza A viruses in children treated with oseltamivir: descriptive study.	Lancet	2004	194
15353055	4758	Viboud C	Risk factors of influenza transmission in households.	The British journal of general practice 	2004	101
15470432	4758	Kobasa D	Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.	Nature	2004	139
16228009	4758	Le QM	Avian flu: isolation of drug-resistant H5N1 virus.	Nature	2005	196
16229762	4758	Gani R	Potential impact of antiviral drug use during influenza pandemic.	Emerging infectious diseases	2005	68
16371632	4758	de Jong MD	Oseltamivir resistance during treatment of influenza A (H5N1) infection.	The New England journal of medicine	2005	238
16420364	4758	King SJ	Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae.	Molecular microbiology	2006	82
17109288	4758	Baz M	Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.	Clinical infectious diseases 	2006	63
18374680	4758	Rothberg MB	Complications of viral influenza.	The American journal of medicine	2008	91
19687228	4758	Uchiyama S	The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion.	The Journal of experimental medicine	2009	47
19696719	4758	Centers for Disease Control and Prevention (CDC).	Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009.	MMWR. Morbidity and mortality weekly report	2009	73
19745803	4758	Centers for Disease Control and Prevention (CDC).	Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.	MMWR. Morbidity and mortality weekly report	2009	76
19822626	4758	Domínguez-Cherit G	Critically Ill patients with 2009 influenza A(H1N1) in Mexico.	JAMA	2009	211
19822627	4758	Kumar A	Critically ill patients with 2009 influenza A(H1N1) infection in Canada.	JAMA	2009	296
20080770	4758	Kiso M	T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.	Proceedings of the National Academy of Sciences of the United States of America	2010	50
21288815	4758	Ghedin E	Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance.	The Journal of infectious diseases	2011	39
21342900	4758	Skarbinski J	Hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in the United States--September-October 2009.	Clinical infectious diseases 	2011	36
21345415	4758	Mosby LG	2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature.	American journal of obstetrics and gynecology	2011	43
21435708	4758	Ruuskanen O	Viral pneumonia.	Lancet	2011	133
22258996	4758	Jefferson T	Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.	The Cochrane database of systematic reviews	2012	52
22561367	4758	Hurt AC	Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.	The Journal of infectious diseases	2012	35
23307936	4758	Couch RB	Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.	The Journal of infectious diseases	2013	39
24718923	4758	Jefferson T	Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.	The Cochrane database of systematic reviews	2014	70
24815805	4758	Muthuri SG	Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.	The Lancet. Respiratory medicine	2014	69
1694727	4763	Viskochil D	Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.	Cell	1990	165
11894862	4763	Ferner RE	International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.	Cancer research	2002	89
12011145	4763	Evans DG	Malignant peripheral nerve sheath tumours in neurofibromatosis 1.	Journal of medical genetics	2002	157
16217056	4763	Hyman SL	The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.	Neurology	2005	76
17283119	4763	Sharma MK	Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin.	Cancer research	2007	59
17387725	4763	Listernick R	Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.	Annals of neurology	2007	64
19474676	4763	Zou C	Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.	Annals of surgery	2009	50
19539839	4763	Boyd KP	Neurofibromatosis type 1.	Journal of the American Academy of Dermatology	2009	54
19576851	4763	van Nederveen FH	An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.	The Lancet. Oncology	2009	69
20027112	4763	Jett K	Clinical and genetic aspects of neurofibromatosis 1.	Genetics in medicine 	2010	59
23099009	4763	Robertson KA	Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.	The Lancet. Oncology	2012	33
23205844	4763	van Eeghen AM	Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach.	Developmental medicine and child neurology	2013	28
26580448	4763	Zhang J	Germline Mutations in Predisposition Genes in Pediatric Cancer.	The New England journal of medicine	2015	43
27165744	4763	Zheng S	Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.	Cancer cell	2016	23
9513736	5020	Modahl C	Plasma oxytocin levels in autistic children.	Biological psychiatry	1998	133
16890230	5020	Lim MM	Neuropeptidergic regulation of affiliative behavior and social bonding in animals.	Hormones and behavior	2006	133
17888410	5020	Guastella AJ	Oxytocin increases gaze to the eye region of human faces.	Biological psychiatry	2008	148
17958710	5020	Feldman R	Evidence for a neuroendocrinological foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding.	Psychological science	2007	115
18221838	5020	Savaskan E	Post-learning intranasal oxytocin modulates human memory for facial identity.	Psychoneuroendocrinology	2008	62
18343353	5020	Guastella AJ	Oxytocin enhances the encoding of positive social memories in humans.	Biological psychiatry	2008	72
19344725	5020	Theodoridou A	Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness.	Hormones and behavior	2009	53
19710635	5020	Strathearn L	Adult attachment predicts maternal brain and oxytocin response to infant cues.	Neuropsychopharmacology 	2009	126
20153585	5020	Feldman R	Natural variations in maternal and paternal care are associated with systematic changes in oxytocin following parent-infant contact.	Psychoneuroendocrinology	2010	83
20160081	5020	Andari E	Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.	Proceedings of the National Academy of Sciences of the United States of America	2010	205
20424014	5020	Taylor SE	Are plasma oxytocin in women and plasma vasopressin in men biomarkers of distressed pair-bond relationships?	Psychological science	2010	43
20462908	5020	Seltzer LJ	Social vocalizations can release oxytocin in humans.	Proceedings. Biological sciences	2010	51
20947304	5020	Rubin LH	Peripheral oxytocin is associated with reduced symptom severity in schizophrenia.	Schizophrenia research	2010	47
21470595	5020	Riem MM	Oxytocin modulates amygdala, insula, and inferior frontal gyrus responses to infant crying: a randomized controlled trial.	Biological psychiatry	2011	80
21562482	5020	Skrundz M	Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression.	Neuropsychopharmacology 	2011	48
21676095	5020	Feldman R	Maternal and paternal plasma, salivary, and urinary oxytocin and parent-infant synchrony: considering stress and affiliation components of human bonding.	Developmental science	2011	62
21840177	5020	Pedersen CA	Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.	Schizophrenia research	2011	59
21881566	5020	Atzil S	Specifying the neurobiological basis of human attachment: brain, hormones, and behavior in synchronous and intrusive mothers.	Neuropsychopharmacology 	2011	50
22189289	5020	Riem MM	No laughing matter: intranasal oxytocin administration changes functional brain connectivity during exposure to infant laughter.	Neuropsychopharmacology 	2012	39
22285934	5020	Feldman R	Oxytocin and social affiliation in humans.	Hormones and behavior	2012	79
22336563	5020	Feldman R	Sensitive parenting is associated with plasma oxytocin and polymorphisms in the OXTR and CD38 genes.	Biological psychiatry	2012	70
22795645	5020	Weisman O	Oxytocin administration to parent enhances infant physiological and behavioral readiness for social engagement.	Biological psychiatry	2012	39
22981649	5020	Lukas M	Oxytocin and vasopressin in rodent behaviors related to social dysfunctions in autism spectrum disorders.	Behavioural brain research	2013	26
23325323	5020	Feldman R	Parental oxytocin and early caregiving jointly shape children's oxytocin response and social reciprocity.	Neuropsychopharmacology 	2013	34
23413037	5020	Miller M	Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms.	Autism research 	2013	28
23510581	5020	Domes G	Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder.	Biological psychiatry	2013	43
23695233	5020	Bakermans-Kranenburg MJ	Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy.	Translational psychiatry	2013	68
23846912	5020	Apter-Levy Y	Impact of maternal depression across the first 6 years of life on the child's mental health, social engagement, and empathy: The moderating role of oxytocin.	The American journal of psychiatry	2013	30
23856187	5020	Olff M	The role of oxytocin in social bonding, stress regulation and mental health: an update on the moderating effects of context and interindividual differences.	Psychoneuroendocrinology	2013	50
23888359	5020	Dadds MR	Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial.	Journal of autism and developmental disorders	2014	38
24050183	5020	Carter CS	Oxytocin pathways and the evolution of human behavior.	Annual review of psychology	2014	60
24059811	5020	Dadds MR	Methylation of the oxytocin receptor gene and oxytocin blood levels in the development of psychopathy.	Development and psychopathology	2014	25
24297883	5020	Gordon I	Oxytocin enhances brain function in children with autism.	Proceedings of the National Academy of Sciences of the United States of America	2013	63
25092315	5020	Parker KJ	Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder.	Proceedings of the National Academy of Sciences of the United States of America	2014	31
25349162	5020	Carson DS	Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children.	Molecular psychiatry	2015	23
26503762	5020	Yatawara CJ	The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.	Molecular psychiatry	2016	34
11860058	5079	Chassin L	Binge drinking trajectories from adolescence to emerging adulthood in a high-risk sample: predictors and substance abuse outcomes.	Journal of consulting and clinical psychology	2002	175
12093997	5079	Story MT	Management of child and adolescent obesity: attitudes, barriers, skills, and training needs among health care professionals.	Pediatrics	2002	88
15867049	5079	Owen CG	Effect of infant feeding on the risk of obesity across the life course: a quantitative review of published evidence.	Pediatrics	2005	184
16815322	5079	Hudson JI	The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.	Biological psychiatry	2007	605
17344859	5079	Mullighan CG	Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.	Nature	2007	467
19548833	5079	Berkley JA	HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria.	Clinical infectious diseases 	2009	67
20142280	5079	Anderson SE	Household routines and obesity in US preschool-aged children.	Pediatrics	2010	78
22215165	5079	Bray GA	Effect of dietary protein content on weight gain, energy expenditure, and body composition during overeating: a randomized controlled trial.	JAMA	2012	57
22541246	5079	Henderson CJ	Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis.	The Journal of allergy and clinical immunology	2012	38
24231879	5079	Yanovski SZ	Long-term drug treatment for obesity: a systematic and clinical review.	JAMA	2014	70
12611666	5091	Schantz SL	Effects of PCB exposure on neuropsychological function in children.	Environmental health perspectives	2003	91
16002372	5091	Schisterman EF	Lipid adjustment in the analysis of environmental contaminants and human health risks.	Environmental health perspectives	2005	113
19320182	5091	Patterson DG Jr	Levels in the U.S. population of those persistent organic pollutants (2003-2004) included in the Stockholm Convention or in other long range transboundary air pollution agreements.	Environmental science and technology	2009	51
20829149	5091	Eubig PA	Lead and PCBs as risk factors for attention deficit/hyperactivity disorder.	Environmental health perspectives	2010	54
22027556	5091	Valvi D	Prenatal concentrations of polychlorinated biphenyls, DDE, and DDT and overweight in children: a prospective birth cohort study.	Environmental health perspectives	2012	38
23151773	5091	Buck Louis GM	Persistent environmental pollutants and couple fecundity: the LIFE study.	Environmental health perspectives	2013	37
25510359	5091	Ampleman MD	Inhalation and dietary exposure to PCBs in urban and rural cohorts via congener-specific measurements.	Environmental science and technology	2015	17
14672642	5187	Burdette HL	Neighborhood playgrounds, fast food restaurants, and crime: relationships to overweight in low-income preschool children.	Preventive medicine	2004	103
16050886	5187	Insinga RP	The incidence of herpes zoster in a United States administrative database.	Journal of general internal medicine	2005	88
18071068	5187	Khairy P	Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery.	Circulation	2008	67
18817553	5187	Modell B	Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance.	Journal of cardiovascular magnetic resonance 	2008	85
18972721	5187	Mathews TJ	Infant mortality statistics from the 2005 period linked birth/infant death data set.	National vital statistics reports 	2008	66
19037006	5187	Rahman A	Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh.	American journal of epidemiology	2009	68
21254725	5187	Martin JA	Births: final data for 2007.	National vital statistics reports 	2010	109
22383946	5187	Becquet R	Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis.	PloS one	2012	38
23168270	5187	Hiza HA	Diet quality of Americans differs by age, sex, race/ethnicity, income, and education level.	Journal of the Academy of Nutrition and Dietetics	2013	58
24115913	5187	Baguelin M	Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.	PLoS medicine	2013	38
24488779	5187	Ward E	Childhood and adolescent cancer statistics, 2014.	CA	2014	139
24735562	5187	Matthews TJ	Infant mortality statistics from the 2010 period linked birth/infant death data set.	National vital statistics reports 	2013	45
24974589	5187	Martin JA	Births: final data for 2010.	National vital statistics reports 	2012	111
24979973	5187	Hamilton BE	Births: preliminary data for 2011.	National vital statistics reports 	2012	45
24979974	5187	Mathews TJ	Infant mortality statistics from the 2009 period linked birth/infant death data set.	National vital statistics reports 	2013	25
25252091	5187	MacDorman MF	International comparisons of infant mortality and related factors: United States and Europe, 2010.	National vital statistics reports 	2014	24
25671704	5187	Martin JA	Births: final data for 2012.	National vital statistics reports 	2013	42
15001609	5741	Parikh SJ	The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults.	The Journal of clinical endocrinology and metabolism	2004	116
15671234	5741	Hollis BW	Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D.	The Journal of nutrition	2005	206
15883429	5741	Sachan A	High prevalence of vitamin D deficiency among pregnant women and their newborns in northern India.	The American journal of clinical nutrition	2005	78
18088161	5741	Cranney A	Effectiveness and safety of vitamin D in relation to bone health.	Evidence report/technology assessment	2007	106
20139235	5741	Viljakainen HT	Maternal vitamin D status determines bone variables in the newborn.	The Journal of clinical endocrinology and metabolism	2010	46
20593414	5741	Jüppner H	FGF-23: More than a regulator of renal phosphate handling?	Journal of bone and mineral research 	2010	44
20861820	5741	Wesseling-Perry K	Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.	Kidney international	2011	47
22052943	5741	Wesseling-Perry K	Early skeletal and biochemical alterations in pediatric chronic kidney disease.	Clinical journal of the American Society of Nephrology 	2012	33
17596254	6240	Mrisho M	Factors affecting home delivery in rural Tanzania.	Tropical medicine and international health 	2007	87
19949966	6240	Baliunas D	Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis.	International journal of public health	2010	81
20085532	6240	Salmasi G	Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses.	Acta obstetricia et gynecologica Scandinavica	2010	52
23449641	6240	Hansen M	Assisted reproductive technology and birth defects: a systematic review and meta-analysis.	Human reproduction update	2013	30
23839868	6240	Civljak M	Internet-based interventions for smoking cessation.	The Cochrane database of systematic reviews	2013	71
26453266	6240	Qin J	Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies.	Fertility and sterility	2016	14
11359211	6323	Claes L	De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.	American journal of human genetics	2001	160
17347258	6323	Harkin LA	The spectrum of SCN1A-related infantile epileptic encephalopathies.	Brain 	2007	64
20194124	6323	Catterall WA	NaV1.1 channels and epilepsy.	The Journal of physiology	2010	84
21463272	6323	Dravet C	The core Dravet syndrome phenotype.	Epilepsia	2011	43
24874546	6323	Estacion M	A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.	Neurobiology of disease	2014	29
27270488	6323	Meisler MH	SCN8A encephalopathy: Research progress and prospects.	Epilepsia	2016	13
8929413	6532	Lesch KP	Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.	Science	1996	867
11602621	6532	Eddahibi S	Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.	The Journal of clinical investigation	2001	100
12869766	6532	Caspi A	Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.	Science	2003	1436
15563601	6532	Kaufman J	Social supports and serotonin transporter gene moderate depression in maltreated children.	Proceedings of the National Academy of Sciences of the United States of America	2004	187
16012532	6532	Maciag D	Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.	Neuropsychopharmacology 	2006	70
16212676	6532	Sjöberg RL	Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene.	The international journal of neuropsychopharmacology	2006	70
16934775	6532	Taylor SE	Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology.	Biological psychiatry	2006	120
17123474	6532	Kaufman J	Genetic and environmental predictors of early alcohol use.	Biological psychiatry	2007	64
17700575	6532	Uher R	The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis.	Molecular psychiatry	2008	149
17974934	6532	Kilpatrick DG	The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults.	The American journal of psychiatry	2007	113
18005940	6532	Gotlib IH	HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression.	Biological psychiatry	2008	136
18458203	6532	Eaton WW	Population-based study of first onset and chronicity in major depressive disorder.	Archives of general psychiatry	2008	72
19207629	6532	Kochanska G	Interplay of genes and early mother-child relationship in the development of self-regulation from toddler to preschool age.	Journal of child psychology and psychiatry, and allied disciplines	2009	48
19437301	6532	Gibb BE	Children's attentional biases and 5-HTTLPR genotype: potential mechanisms linking mother and child depression.	Journal of clinical child and adolescent psychology 	2009	49
19439600	6532	Pacheco J	Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism.	The Journal of neuroscience 	2009	51
19739105	6532	Beach SRH	Methylation at SLC6A4 is linked to family history of child abuse: an examination of the Iowa Adoptee sample.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2010	63
19884608	6532	Xie P	Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations.	Archives of general psychiatry	2009	86
20398062	6532	Kinnally EL	Epigenetic regulation of serotonin transporter expression and behavior in infant rhesus macaques.	Genes, brain, and behavior	2010	54
20591416	6532	van IJzendoorn MH	Methylation matters: interaction between methylation density and serotonin transporter genotype predicts unresolved loss or trauma.	Biological psychiatry	2010	48
21608084	6532	Koenen KC	SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder.	Depression and anxiety	2011	45
22833190	6532	Hankin BL	Differential susceptibility in youth: evidence that 5-HTTLPR x positive parenting is associated with positive affect 'for better and worse'.	Translational psychiatry	2011	43
23154100	6532	Bailer UF	Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.	Psychiatry research	2013	25
25086606	6532	Nikolova YS	Beyond genotype: serotonin transporter epigenetic modification predicts human brain function.	Nature neuroscience	2014	31
16585942	6717	Bloch MH	A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.	Molecular psychiatry	2006	79
17478440	6717	Kelishadi R	Childhood overweight, obesity, and the metabolic syndrome in developing countries.	Epidemiologic reviews	2007	145
19027102	6717	Pavuluri MN	Diffusion tensor imaging study of white matter fiber tracts in pediatric bipolar disorder and attention-deficit/hyperactivity disorder.	Biological psychiatry	2009	63
20071021	6717	Lumbiganon P	Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08.	Lancet	2010	115
25104345	6717	Fulu E	Prevalence of and factors associated with male perpetration of intimate partner violence: findings from the UN Multi-country Cross-sectional Study on Men and Violence in Asia and the Pacific.	The Lancet. Global health	2013	36
26385074	6717	Ng SC	Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia.	Gastroenterology	2016	11
15625418	7052	Hill ID	Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.	Journal of pediatric gastroenterology and nutrition	2005	133
17032199	7052	Stene LC	Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study.	The American journal of gastroenterology	2006	86
19362553	7052	Rubio-Tapia A	Increased prevalence and mortality in undiagnosed celiac disease.	Gastroenterology	2009	128
19516192	7052	Myléus A	Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic.	Journal of pediatric gastroenterology and nutrition	2009	49
21070098	7052	Mustalahti K	The prevalence of celiac disease in Europe: results of a centralized, international mass screening project.	Annals of medicine	2010	91
22138844	7052	Volta U	Serological tests in gluten sensitivity (nonceliac gluten intolerance).	Journal of clinical gastroenterology	2012	35
25601977	7052	Aronsson CA	Age at gluten introduction and risk of celiac disease.	Pediatrics	2015	20
15589690	9933	Ratledge C	Fatty acid biosynthesis in microorganisms being used for Single Cell Oil production.	Biochimie	2004	73
17688705	9933	Koletzko B	Dietary fat intakes for pregnant and lactating women.	The British journal of nutrition	2007	57
18184094	9933	Koletzko B	The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations.	Journal of perinatal medicine	2008	75
20124114	9933	Amminger GP	Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.	Archives of general psychiatry	2010	182
22841917	9933	Luchtman DW	Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies.	Neuropharmacology	2013	41
12512033	10133	Wiesner R	Model for end-stage liver disease (MELD) and allocation of donor livers.	Gastroenterology	2003	240
20428114	10133	Maruyama H	Mutations of optineurin in amyotrophic lateral sclerosis.	Nature	2010	227
23237695	10133	Matas AJ	OPTN/SRTR 2011 Annual Data Report: kidney.	American journal of transplantation 	2013	39
24373166	10133	Matas AJ	OPTN/SRTR 2012 Annual Data Report: kidney.	American journal of transplantation 	2014	67
24373168	10133	Kim WR	OPTN/SRTR 2012 Annual Data Report: liver.	American journal of transplantation 	2014	38
25700176	10133	Cirulli ET	Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.	Science	2015	115
8427558	10163	Regier DA	The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.	Archives of general psychiatry	1993	250
19188537	10163	Elbogen EB	The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.	Archives of general psychiatry	2009	79
20973600	10163	Carstensen LL	Emotional experience improves with age: evidence based on over 10 years of experience sampling.	Psychology and aging	2011	110
23230075	10163	Exner-Cortens D	Longitudinal associations between teen dating violence victimization and adverse health outcomes.	Pediatrics	2013	40
23283715	10163	Kowal P	Data resource profile: the World Health Organization Study on global AGEing and adult health (SAGE).	International journal of epidemiology	2012	109
9358137	10242	Pauwels RA	Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.	The New England journal of medicine	1997	191
9918525	10242	Bowling N	Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart.	Circulation	1999	99
10573240	10242	Juniper EF	Development and validation of a questionnaire to measure asthma control.	The European respiratory journal	1999	290
15500895	10242	Israel E	Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.	Lancet	2004	106
15502112	10242	O'Byrne PM	Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.	American journal of respiratory and critical care medicine	2005	80
15516534	10242	Sigurs N	Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.	American journal of respiratory and critical care medicine	2005	180
16226443	10242	Juniper EF	Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire.	Respiratory medicine	2006	103
16424409	10242	Nelson HS	The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.	Chest	2006	163
16635265	10242	Nyarango PM	A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods.	Malaria journal	2006	116
17928596	10242	Bisgaard H	Childhood asthma after bacterial colonization of the airway in neonates.	The New England journal of medicine	2007	151
18827155	10242	Brand PL	Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach.	The European respiratory journal	2008	75
19237679	10242	Licht CM	Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension.	Hypertension	2009	48
20106747	10242	Engel SM	Prenatal phthalate exposure is associated with childhood behavior and executive functioning.	Environmental health perspectives	2010	86
20186367	10242	Lougheed MD	Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults.	Canadian respiratory journal	2010	53
22536582	10242	Lougheed MD	Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults.	Canadian respiratory journal	2012	52
24414989	10242	Normansell R	Omalizumab for asthma in adults and children.	The Cochrane database of systematic reviews	2014	44
18768390	10320	Yang JJ	Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.	Blood	2008	55
19129520	10320	Mullighan CG	Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.	The New England journal of medicine	2009	274
19138562	10320	Den Boer ML	A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.	The Lancet. Oncology	2009	145
19589926	10320	Iacobucci I	Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).	Blood	2009	50
19770381	10320	Martinelli G	IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.	Journal of clinical oncology 	2009	61
19880498	10320	Kang H	Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.	Blood	2010	59
20139093	10320	Harvey RC	Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.	Blood	2010	112
20445578	10320	Kuiper RP	IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.	Leukemia	2010	57
20699438	10320	Harvey RC	Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.	Blood	2010	113
21642990	10320	Mavrakis KJ	A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL).	Nature genetics	2011	84
22368272	10320	Chen IM	Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.	Blood	2012	59
23212523	10320	Loh ML	Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.	Blood	2013	32
23512250	10320	Xu H	Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.	Journal of the National Cancer Institute	2013	49
23974192	10320	van der Veer A	Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.	Blood	2013	42
24366361	10320	van der Veer A	IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.	Blood	2014	25
24740809	10320	Beldjord K	Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.	Blood	2014	23
26200652	10320	Vučković F	Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome.	Arthritis and rheumatology	2015	16
26219304	10320	Song C	Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.	Blood	2015	16
12355369	10625	Libraty DH	High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.	The Journal of infectious diseases	2002	158
15827150	10625	Spann KM	Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines.	Journal of virology	2005	95
16544248	10625	Avirutnan P	Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement.	The Journal of infectious diseases	2006	114
19072716	10625	Kapoor A	A newly identified bocavirus species in human stool.	The Journal of infectious diseases	2009	88
19156192	10625	Hang VT	Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses.	PLoS neglected tropical diseases	2009	71
20509940	10625	Tricou V	Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses.	BMC infectious diseases	2010	42
20706626	10625	Tricou V	A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.	PLoS neglected tropical diseases	2010	48
20824173	10625	Guzman MG	Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis.	PLoS neglected tropical diseases	2010	46
21909448	10625	Tricou V	Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue.	PLoS neglected tropical diseases	2011	46
21963675	10625	Collins PL	Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.	Virus research	2011	113
22441389	10625	Blacksell SD	Comparison of seven commercial antigen and antibody enzyme-linked immunosorbent assays for detection of acute dengue infection.	Clinical and vaccine immunology 	2012	31
24767772	10625	Aye KS	Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar.	Human pathology	2014	25
11905807	26284	Knudson AG	Two genetic hits (more or less) to cancer.	Nature reviews. Cancer	2001	183
20595106	26284	Jain AK	Tuberculosis of the spine: a fresh look at an old disease.	The Journal of bone and joint surgery. British volume	2010	63
24759657	26284	Whitney CG	Benefits from immunization during the vaccines for children program era - United States, 1994-2013.	MMWR. Morbidity and mortality weekly report	2014	27
9237695	26503	Kalayanarooj S	Early clinical and laboratory indicators of acute dengue illness.	The Journal of infectious diseases	1997	108
17393509	26503	Angulo P	The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.	Hepatology	2007	235
18390575	26503	Harrison SA	Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.	Gut	2008	92
19013463	26503	Patton HM	Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.	Gastroenterology	2008	50
19043581	26503	Weissman JR	Mitochondrial disease in autism spectrum disorder patients: a cohort analysis.	PloS one	2008	54
19148800	26503	Hashimoto E	Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.	Journal of gastroenterology	2009	50
19706703	26503	Finkbeiner SR	Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis.	Journal of virology	2009	62
23316013	26503	Sieghart W	The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma.	Hepatology	2013	37
11015506	55016	Costeloe K	The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability.	Pediatrics	2000	95
19274071	55016	Sissoko D	Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period.	PLoS neglected tropical diseases	2009	60
19498336	55016	Centers for Disease Control and Prevention (CDC).	Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009.	MMWR. Morbidity and mortality weekly report	2009	49
22914561	55016	Feikin DR	Viral and bacterial causes of severe acute respiratory illness among children aged less than 5 years in a high malaria prevalence area of western Kenya, 2007-2010.	The Pediatric infectious disease journal	2013	31
22937071	55016	Feikin DR	Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010.	PloS one	2012	43
25686473	55016	Beidas RS	Predictors of community therapists' use of therapy techniques in a large public mental health system.	JAMA pediatrics	2015	20
26348249	55016	Primack BA	Progression to Traditional Cigarette Smoking After Electronic Cigarette Use Among US Adolescents and Young Adults.	JAMA pediatrics	2015	67
26993883	55016	Cauchemez S	Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study.	Lancet	2016	125
11170305	57142	Menon V	Error-related brain activation during a Go/NoGo response inhibition task.	Human brain mapping	2001	206
16806097	57142	Klein C	Intra-subject variability in attention-deficit hyperactivity disorder.	Biological psychiatry	2006	101
19929943	57142	Uebel H	Performance variability, impulsivity errors and the impact of incentives as gender-independent endophenotypes for ADHD.	Journal of child psychology and psychiatry, and allied disciplines	2010	47
21399712	57142	Tottenham N	Elevated amygdala response to faces following early deprivation.	Developmental science	2011	97
21876169	57142	Casey BJ	Behavioral and neural correlates of delay of gratification 40 years later.	Proceedings of the National Academy of Sciences of the United States of America	2011	90
22546743	57142	Kamijo K	The relation of adiposity to cognitive control and scholastic achievement in preadolescent children.	Obesity	2012	38
23498139	57142	Silveri MM	Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition.	Biological psychiatry	2013	27
9272895	57379	Olds DL	Long-term effects of home visitation on maternal life course and child abuse and neglect. Fifteen-year follow-up of a randomized trial.	JAMA	1997	151
11078767	57379	Confavreux C	Relapses and progression of disability in multiple sclerosis.	The New England journal of medicine	2000	113
12472299	57379	Armstrong TD	Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity.	Journal of consulting and clinical psychology	2002	130
12553416	57379	Wood JJ	Parenting and childhood anxiety: theory, empirical findings, and future directions.	Journal of child psychology and psychiatry, and allied disciplines	2003	82
18390709	57379	Frasca D	Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells.	Journal of immunology	2008	79
21609768	57379	Ingalhalikar M	Diffusion based abnormality markers of pathology: toward learned diagnostic prediction of ASD.	NeuroImage	2011	42
21700883	57379	Meyers G	Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans.	Proceedings of the National Academy of Sciences of the United States of America	2011	49
22877506	57379	Wandt H	Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.	Lancet	2012	33
25210150	57379	Dawson PA	Intestinal transport and metabolism of bile acids.	Journal of lipid research	2015	21
16267772	57823	Pai R	Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.	The Journal of infectious diseases	2005	88
16598044	57823	Kyaw MH	Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.	The New England journal of medicine	2006	152
17529860	57823	Pelton SI	Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.	The Pediatric infectious disease journal	2007	90
17922399	57823	Hicks LA	Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.	The Journal of infectious diseases	2007	181
17940232	57823	Pichichero ME	Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.	JAMA	2007	75
18258121	57823	Choi EH	Streptococcus pneumoniae serotype 19A in children, South Korea.	Emerging infectious diseases	2008	59
19564254	57823	Huang SS	Continued impact of pneumococcal conjugate vaccine on carriage in young children.	Pediatrics	2009	98
19947881	57823	Pilishvili T	Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.	The Journal of infectious diseases	2010	282
21150868	57823	Nuorti JP	Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).	MMWR. Recommendations and reports 	2010	90
21398395	57823	Beall BW	Shifting genetic structure of invasive serotype 19A pneumococci in the United States.	The Journal of infectious diseases	2011	46
22374921	57823	Bewick T	Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia.	Thorax	2012	31
23804191	57823	Dagan R	Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.	Clinical infectious diseases 	2013	32
24567842	57823	Lee GM	Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts.	Journal of the Pediatric Infectious Diseases Society	2014	26
24726406	57823	Domingues CM	Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study.	The Lancet. Respiratory medicine	2014	42
26132078	57823	van der Linden M	Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.	PloS one	2015	19
26226445	57823	Desai AP	Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.	The Pediatric infectious disease journal	2015	21
17434869	79068	Frayling TM	A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.	Science	2007	1077
17496892	79068	Dina C	Variation in FTO contributes to childhood obesity and severe adult obesity.	Nature genetics	2007	382
18159244	79068	Hinney A	Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants.	PloS one	2007	167
18335027	79068	Grant SF	Association analysis of the FTO gene with obesity in children of Caucasian and African ancestry reveals a common tagging SNP.	PloS one	2008	77
18583465	79068	Wardle J	Obesity associated genetic variation in FTO is associated with diminished satiety.	The Journal of clinical endocrinology and metabolism	2008	130
18838977	79068	Wardle J	The FTO gene and measured food intake in children.	International journal of obesity	2009	82
18842783	79068	Timpson NJ	The fat mass- and obesity-associated locus and dietary intake in children.	The American journal of clinical nutrition	2008	96
18846049	79068	Haworth CM	Increasing heritability of BMI and stronger associations with the FTO gene over childhood.	Obesity	2008	53
19073975	79068	Cecil JE	An obesity-associated FTO gene variant and increased energy intake in children.	The New England journal of medicine	2008	172
19158205	79068	Hakanen M	FTO genotype is associated with body mass index after the age of seven years but not with energy intake or leisure-time physical activity.	The Journal of clinical endocrinology and metabolism	2009	46
19828706	79068	Tanofsky-Kraff M	The FTO gene rs9939609 obesity-risk allele and loss of control over eating.	The American journal of clinical nutrition	2009	69
21379325	79068	Sovio U	Association between common variation at the FTO locus and changes in body mass index from infancy to late childhood: the complex nature of genetic association through growth and development.	PLoS genetics	2011	57
21555716	79068	Palmer TM	Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses.	American journal of epidemiology	2011	45
22069379	79068	Kilpeläinen TO	Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children.	PLoS medicine	2011	114
23867619	79068	Karra E	A link between FTO, ghrelin, and impaired brain food-cue responsivity.	The Journal of clinical investigation	2013	56
25104851	79068	Qi Q	FTO genetic variants, dietary intake and body mass index: insights from 177,330 individuals.	Human molecular genetics	2014	28
15474134	80150	Roberts I	Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial.	Lancet	2004	106
19124805	80150	Huguet F	Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.	Journal of clinical oncology 	2009	63
12032915	114548	Feldmann J	Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes.	American journal of human genetics	2002	138
12483741	114548	Aksentijevich I	De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.	Arthritis and rheumatism	2002	134
14872505	114548	Hawkins PN	Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.	Arthritis and rheumatism	2004	89
16899778	114548	Goldbach-Mansky R	Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.	The New England journal of medicine	2006	182
17393462	114548	Aksentijevich I	The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.	Arthritis and rheumatism	2007	81
17763411	114548	Gattorno M	Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations.	Arthritis and rheumatism	2007	65
19098911	114548	Villani AC	Common variants in the NLRP3 region contribute to Crohn's disease susceptibility.	Nature genetics	2009	118
19494217	114548	Lachmann HJ	Use of canakinumab in the cryopyrin-associated periodic syndrome.	The New England journal of medicine	2009	137
20039428	114548	Neven B	Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.	Arthritis and rheumatism	2010	52
24398679	114548	Bakele M	Localization and functionality of the inflammasome in neutrophils.	The Journal of biological chemistry	2014	20
24861026	114548	Wree A	NLRP3 inflammasome activation is required for fibrosis development in NAFLD.	Journal of molecular medicine	2014	30
24952504	114548	Baroja-Mazo A	The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response.	Nature immunology	2014	100
25217959	114548	Canna SW	An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.	Nature genetics	2014	53
25730877	114548	Carta S	Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance.	Proceedings of the National Academy of Sciences of the United States of America	2015	16
26972847	114548	Iannitti RG	IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis.	Nature communications	2016	11
27650785	114548	Montesinos J	Impact of the Innate Immune Response in the Actions of Ethanol on the Central Nervous System.	Alcoholism, clinical and experimental research	2016	12
